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1 Introduction 
1.1 Background 
 
 Following the worldwide thalidomide sanitary catastrophe in the late 
fifties of the 20th century, many efforts were put on the development of methods 
detecting the teratogenic potential of substances (e.g., chemicals, drugs or 
pesticides). Currently, developmental toxicity and embryotoxicity are tested 
almost exclusively in vivo, using rats and rabbits as rodent and non-rodent 
model species respectively. In these in vivo tests, the substance is administered 
to pregnant animals and embryotoxic effects are further monitored. According to 
a report from the German ministry namely BMELV (Bundesministerium für 
Ernährung, Landwirtschaft und Verbraucherschutz) more than 4000 animals 
were used in 2006 to test developmental toxicity.  
 
In June 2007 a new chemical regulation system came into force within 
the European Union: REACH (Registration, Evaluation, and Authorization of 
Chemicals). Following REACH, about 30,000 chemicals put on the market 
before 1981 will be reassessed for toxicity, including potential embryotoxic and 
teratogenic activity, within the next 11 years. The number of laboratory animals 
needed for these studies will be tremendous and will raise a justified public 
concern. These apprehensions were already shared by scientists in the late 
1950’s with the concept of 3Rs (Reduce, Refine and Replace) (Russel and 
Burch, 1959) were then persued through governmental authorities such as 
ECVAM (European Centre for the Validation of Alternatives Methods), ICCVAM 
(Interagency Coordinating Comittee on the Validation of Alternatives Methods) 
or ZEBET (Die Zentralstelle zur Erfassung und Bewertung von Ersatz- und 
Ergänzungsmethoden zum Tierversuch) in Germany. 
 
 Currently, there are few alternative methods investigating the 
embryotoxicity and/or teratogenicity of substances. In the 1970ies, the rat whole 
embryo culture was developed, (New, 1978; Webster et al., 1997) followed later 
on with other animal models (e.g., mouse, rabbit). In the late eighties of the last 
century, cell cultures (i.e., embryonic stem cells test, micromass test) and organ 
culture (i.e., lung, sex organs) systems completed this toolbox. However, it is 
highly disadvantageous that some of those models (i) still need animals (rats) to 
obtain the test systems (Piersma, 2004) (ii) in general don’t cover the whole 
period of embryo/fetogenese and (iii) don’t address a possible metabolic 
activation of the test materials (Spielmann et al., 2006). 
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 Nowadays, it is recognised that teratogenic activity is not always due 
to the parent compound but may be caused by one or more metabolites formed 
by maternal metabolism (Fantel, 1982; Webster et al., 1997). These parent 
compounds, termed proteratogens can be enzymatically bioactivated to highly 
toxic electrophiles or free radicals intermediates (Wells et al., 2005). Therefore, 
when the chemicals are unknown or poorly characterized, the addition of a 
mammalian metabolic activation system (e.g., S9-mix, microsomes, 
hepatocytes) to detect proteratogenic potency has been proposed using whole 
embryo systems (Fantel et al., 1979; Zhao et al., 1993). 
 
 The zebrafish Danio rerio embryo, a vertebrate model, combines the 
advantages of cell and embryo culture systems. In the last 40 years, extensive 
studies have been performed on this in vitro model and relevant 
ecotoxicological and toxicological applications have been validated and 
guidelines written (O.E.C.D., 2006). Furthermore, zebrafish D. rerio embryo has 
been promoted as a general model for assessing embryotoxicity and 
teratogenicity, DarT (Danio rerio Teratogenic assay). A scoring system was 
described to assess compounds that trigger teratogenicity (Bachmann, 2002; 
Nagel, 2002). However, the absence of mammalian metabolic systems in the in 
vitro assays  has been a major limitation to their applicability (Spielmann et al., 
2006).  
 
During this thesis we successfully developed the combination of DarT 
with a mammalian metabolic activation system (microsomes), which is 
presented as a new alternative method for complete developmental toxicity 
testing (mDarT).  
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1.2 Teratogenesis 
1.2.1 Origins 
 
 The word teratogenesis literally means the formation of a monstrous or 
misshapen organism and comes from the Greek teras or teratos, meaning 
monster or marvel. In contemporary usage, teratogenesis refers to the 
appearance of malformations in a developing foetus. Teratology is the branch of 
biology that studies causes, mechanisms and manifestations of abnormal 
development. 
 
In ancient time in the past and in various cultures, the born of unusual or 
deformed infants was attributed to causes such as hybridization between 
humans and gods or humans and demons. Among the Ancient Greek´s and 
Romans, there was a tendency to consider monstrous infants divine, and some 
mythologic figures appear to have been derived from terata. In the Europe of 
the fifteenth and sixteenth centuries, malformations were believed to be the 
result of association with demons, witches, or other evil creatures, and both the 
mother and the infant were put to death (Hodgson and Levi, 1997).  
 
 In the 1940ies the work of Warknay and his colleagues demonstrated 
that environmental factors such as maternal dietary deficiencies and irradiation 
could affect the intrauterine growth and development of mammals (Hodgson 
and Levi, 1997). In the late 1950ies, thalidomide was pulled from the general 
market because of its catastrophic adverse effect of teratogenesis such as 
phocomelia (see Thalidomide effects in humans in Fig 1.1).  
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Figure 1-1 Thalidomide major effects in humans (phocomelia)(F.D.A.) 
 
 For a substance to be a teratogen, it must increase significantly the 
occurrence of abnormalities, either structural or functional, in the offspring after 
being administered to either parent before conception, to the female during 
pregnancy, or directly to the developing foetus (Hodgson and Levi, 1997). The 
substance can be a chemical (see ethanol effects in humans in Fig. 1-2), a drug 
(e.g., cocaine), an infectious agent, environmental exposure (e.g., Carbon 
Monoxide) or maternal conditions (e.g., starvation) (Shepard, 1995). 
 
  
 
Figure 1-2 Fetal Alcoholic Syndrome in humans (Wattendorf and Muenke, 2005) 
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 Nowadays, it is recognised that teratogenic activity is not always due 
to the parent compound but may be caused by one or more metabolites formed 
by maternal metabolism (Fantel, 1982; Webster et al., 1997). These parent 
compounds, termed proteratogens can be enzymatically bioactivated to highly 
toxic electrophiles or free radicals intermediates (Wells et al., 2005). For 
example, cyclophosphamide (see effects in humans in Fig. 1.3) is considered to 
be a potent human proteratogen. 
  
 
 
Figure 1-3 Cyclophosphamide major malformations in humans (Sender). 
 Legend: Left: baby with cyclophosphamide major malformations (e.g., cleft
 palate); Right: baby after surgical operation. 
 
1.2.2 General principles 
 
Teratology is based on the following fundamental principles: 
 
• Species sensitivity 
 
Teratogenicity is species specific, as thalidomide example ilustrates. 
Indeed, humans are sensitive to thalidomide, whereas most other mammals are 
quite resistant and only some specific animal strains (certain breeds of the 
rabbit and 8 of 9 primate species) with high doses and at a specific time showed 
concordant malformations to that of humans (Shepard, 1995). 
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• Critical periods 
 
The type of teratogenic response is determined by the specific 
developmental stage of the foetus (Hodgson and Levi, 1997). For example, a 
teratogen is more likely to provoke anatomic defects during organogenesis.  
 
• Initiating mechanisms: 
 
 The maternal metabolism plays an important role for the teratogenic 
potential of a compound, since it can reduce or potencialize its toxic effects. A 
number of xenobiotics can be enzymatically bioactivated by maternal pathways 
and become highly toxic intermediates that bind covalently to embryonic cellular 
macromolecules or initiate the formation of reactive oxygen species (ROS) that 
can lead further to teratogenicity (Wells et al., 2005) (Fig. 1-4). 
 
 The initiating mechanisms of a compound can have consequences at 
different levels of an embryo: (i) on the molecular level, there are gene 
mutations, chromosomal abnormalities, lack of precursors or substrates, 
enzyme inhibitions or cell membrane damages. (ii) On the cellular level, these 
mechanisms lead to cell death and/or lack of cell interaction or migration. (iii) 
On the organism level, if a critical mass of cells is destroyed, there may be too 
few cells to develop normal embryos. 
 
• Access to embryo and foetus 
 
The toxicokinetics of xenobiotics to the embryo and foetus is facilitated 
when the molecule is lipophilic and nonionized at physiological pH. 
Toxicokinetics are further described in chapter 1.4. 
 
• Dose-response relationships 
 
 Most teratogens appear to have a threshold or “no-effect” level below 
which no malformations are observable (Hodgson and Levi, 1997). 
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Figure 1-4 Teratogenesis: Biochemical and molecular determinants of chemical 
teratogenesis mediated by reactive oxygen species (Wells et al., 2005) 
 
1.2.3 Test methods 
1.2.3.1 In vivo methods 
 
Teratogenicity or developmental toxicity testing of chemicals is 
addressed by several international accepted guidelines (e.g., OECD, n°414). 
This guideline defines developmental toxicity as “the study of adverse effects on 
the developing organism that may result from exposure prior to conception, 
during prenatal development, or postnatally to the time of sexual maturation”. 
According to OECD guideline n°414, ”the major manifestations of 
developmental toxicity include (i) death of the organism, (ii) structural 
abnormality, (iii) altered growth and (iv) functional deficiency.”  
 
Developmental toxicity testing is performed using pregnant laboratory 
animals of both (i) rodent species (e.g., rat) and (ii) non-rodent species (e.g., 
rabbit). The test substance is administered daily to pregnant animals from 
implantation to one day prior to scheduled kill.  
 
 According to OECD guideline n°414, four groups (three test items and 
one control group) of 20 animals are required for a test substance. The highest 
dose should induce maternal toxicity but not death or severe suffering. One 
intermediate dose level should produce developmental toxicity effects and the 
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lowest dose should not produce any evidence of either maternal or 
developmental toxicity (O.E.C.D., 2001). 
 
 A clear advantage of this test is that it covers a relatively long period, 
from the implantation to the end of the foetogenesis, in which teratogens, and 
probably proteratogens, can be detected. However, it is acknowledged that the 
existing in vivo assays for developmental toxicity are very time consuming, 
laborious, expensive and conflicting with the current needs for rapid screenings 
of potential drugs (Daston, 1996). Furthermore, it involves the use of many 
laboratory animals which disagrees with an increasing political and public 
demand for a reduction in the use of laboratory animals (Walmod et al., 2004). 
 
1.2.3.2 In vitro methods 
1.2.3.2.1 Overview 
 
Alternative methods for developmental toxicity testing can be divided into 
three types of systems with increasing complexity: cell cultures, organ cultures, 
and whole-embryo cultures (WEC). Cell cultures have the disadvantage of 
simplicity with the advantages of ease of performance and minimal or no animal 
use. On the other end of the spectrum WEC are more laborious and require the 
use of more animals.  
 
1.2.3.2.2 Micromass assay 
 
The Micromass (MM) assay may use cultures of limb bud cells, neuronal 
cells or both. Cells are plated at high density and undergo differenciation into 
chondrocytes or neurons without additional stimulation. As a routine in vitro 
teratogenesis screening test, chondrocytes are cultivated in microtiter plates 
with substances and chondrogenesis and cell proliferation are simultaneously 
assessed after six days (Renault et al., 1989). However, MM culture systems 
still require the primary culture of cells isolated from embryos (Huggins, 2003). 
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1.2.3.2.3 Embryonic stem cell test 
 
The embryonic stem cell lines can be established from mammalian 
blastocysts and maintained in an undifferenciated state in the presence of 
feeder layers and/or purified leukemia inhibitory factor.  
 
In 1997 Spielmann and his collegues developed an embryonic stem cell 
(EST) test composed of two permanent mouse cell lines, 3T3 fibroblasts and 
embryonic stem cells (D3). Using three endpoints (inhibition of differenciation of 
ES cells into cardiac myoblasts and cytotoxicity of ES cells and 3T3 cells) a 
classification scheme for chemicals embryotoxicity was assigned to three 
classes: not embryotoxic, moderately embryotoxic and strongly embryotoxic 
(Spielmann et al., 1997)(Huggins, 2003). However, EST lacks so far metabolic 
activation system. 
 
1.2.3.2.4  Whole-embryo culture assay 
 
Mammalian embryo cultures are derived from mice, rats or rabbits 
although rats are the most studied species. In this test, the conceptus is 
cultured in medium under defined gassing conditions for 24-48 hours. A number 
of endpoints can be measured such as effects on development of the visceral 
yolk sac vascularisation and circulation; effects on haematopoiesis; embryonic 
growth and differenciation; and dysmorphogenic effects (Brown et al., 1995; 
Flick and Klug, 2006). 
 
The ECVAM had indicated that the rat whole embryo culture is a 
valuable tool considering its extensive use in many laboratories, its ability to 
detect dysmorphogenesis in embryos and its capacity to incorporate metabolic 
activation systems. They caution, however, that the system is limited in that it is 
complex, covers only a part of organogenesis and requires a fairly high level of 
sophistication to perform (Huggins, 2003). 
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1.2.3.2.4.1 Frog embryo teratogenesis assay (Xenopus) 
 
The frog embryo teratogenesis assay (Xenopus) (FETAX) evaluates the 
effect of toxicants on the development of embryos from a non-mammalian 
species, the South African clawed frog (Xenopus Laevis). FETAX measures 
mortality, malformations and growth inhibition in 96 hours (Fort et al., 1988). 
 
The rationale behind using FETAX as a monitor for teratogenic events in 
mammals is that embryonic development during the first 96 hours in Xenopus 
parallels many of the major processes of human organogenesis and that 
metabolic activation systems can be incorporated (Huggins, 2003). 
 
1.3 The Zebrafish D. rerio 
1.3.1 Animal model description 
 
 The zebrafish D. rerio, a popular aquarium fish (Fig. 1-5), is a member 
of the family Cyprinidae and is native from Bengal to the Coromandel Coast of 
India (Hizaoka and Battle, 1958). It is ideally suited to study the fundamental 
processes underlying embryonic development. In recent years, it has become 
an important model organism in genetic, developmental biology, ecotoxicology 
and toxicology. The development of the zebrafish is very similar to the 
embryogenesis in higher vertebrates, including humans.  
 
 A single female can lay up to 400 eggs per week under laboratory 
conditions and spawn throughout the year (Laale, 1977). Zebrafish develops 
outside the female body and the shell of their eggs (chorion) is completely 
transparent enabling the detailed observation of the developing embryo very 
easily (Fig. 1-6). Additionally, the embryos themselves are transparent during 
the first few days of their lives – yielding a unique possibility to examine the 
formation of internal organs "live" inside the living organism. The embryonic 
development of zebrafish is very rapid: In the first 24 hpf (hours post 
fertilization), all major organs are formed and by the third day of development 
the fish hatch (Dahm and Geisler, 2006). 
 
In contrast to larger species, the size of the larval and adult zebrafish 
minimizes costs through low quantities of dosing solutions and thereby creates 
limited volumes of waste for disposal and minimizes quantities of labware and 
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chemicals for performing various assays and histological assessments (Hill et 
al., 2005). 
 
 These advantages – large number of offspring, rapid embryonic 
development, transparency of the embryos and small size – make the zebrafish 
an ideal model organism to study various aspects of the development process 
in vertebrates. 
 
 
 
Figure 1-5 Zebrafish (D. rerio) females (upper individual) can easily be differentiated from 
males (lower individual) by their extended bellies and the lack of reddish tint 
along the silvery longitudinal lines (Braunbeck et al., 2005) 
 
1.3.2 Embryonic development 
 
 The different stages in zebrafish embryonic development until hatching 
are given in Table 1-1 and relevant embryonic stadium were outlined in Figure 
1-6. 
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Table 1-1 Stages of embryonic development of the zebrafish D. rerio at 26 ± 1°C (Kimmel 
et al., 1995) 
 
Time 
(hpf) 
Stage Characterization 
0 Fertilization Zygote 
0 Zygote period Cytoplasm accumulates at the animal pole, 1 cell-stage 
0.75 Cleavage 
period 
Discoidal partial cleavage 
  1. median vertical division: 2-cell-stage 
1  2. vertical division: 4-cell-stage 
1.25  3. vertical and parallel to the plane of the first: 8-cell-stage 
1.5  4. vertical and parallel to the second plane of division: 16-cell-
stage 
2 Blastula period Start of blastula stage 
3  Late cleavage; blastodisc contains approximately 256 
blastomers 
4  Flat interface between blastoderm and yolk 
5.25 Gastrula period 50% of epibolic movement; blastoderms thin and interface 
between periblast and blastoderm becomes curved 
8  75% of epibolic movement 
10  Epibolic movement ends, blastopore is nearly closed 
10.5 Segmentation 
period 
First somite furrow 
12  Somites are developed, undifferenciated mesodermal 
component of the early trunk, tail segment or metamere 
22  Side to side flextures; otoliths 
24 Pharyngula 
period 
Phylotypic stage, spontaneous movement, tail is detached 
from the yolk, early pigmentation 
30  Reduced spontaneous movement; retina pigmented, cellular 
degeneration of the tail end; circulation in the aortic arch 1 
36  Tail pigmentation; strong circulation; single aortic arch pair, 
early motility; heart beating starts 
72-96 Hatching 
period 
Regular heart-beat; yolk extension beginning to taper; dorsal 
and ventral stripes meets at tail; segmental blood vessels; 
thickened sacculus with 2 chambers; foregut developmental; 
neuromasts 
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Figure 1-6 Inverted microscope observation of important developing stages of the 
zebrafish D. rerio at 26°C 
    A. 8 cells, 1 hpf. B. Somites, 12 hpf. C. Tail detached, 24 hpf. D. Pigmentation, 48 
    hpf. Abbreviations: E: Eye; ET: End Tail; hpf: hours post fertilization; Ht: Heart*; 
    SC: Spinal Cord; S/O: Sacculi/Otoliths*; SM: Somites*; T: Tail; YS: Yolk sac*; YSE: 
    Yolk sac extension*; *: See Glossary. 
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1.3.3  The Zebrafish D. rerio in Ecotoxicology and Toxicology 
1.3.3.1 Zebrafish D. rerio embryo assays in Ecotoxicology 
1.3.3.1.1 Alternative to the acute fish test 
 
The zebrafish is worldwide used to test the acute toxicity of chemicals to 
fishes (O.E.C.D., 1992). In 1994, Schulte and Nagel proposed the embryo test 
as an alternative to the fish acute toxicity test in order to reduce animal tests 
(Schulte and Nagel, 1994). Furthermore, toxicity results obtained with the 
embryo test are in good accordance with the ones obtained with the juvenile or 
adult fish acute toxicity test. (Nagel, 2002). In May 2006, the fish embryo test 
was described in a draft guideline from OECD for the testing of chemicals (see 
Fig. 1.7). 
 
1.3.3.1.2 A model in routine waste water control 
 
The “Goldorfentest” was used as a standard method to assess waste 
water toxicity using adult Goldorf fishes. In 1995, Friccius and his coworkers 
tested the applicability of the zebrafish embryo test in 29 samples of industrial 
effluents from 11 different sewage plants (Friccius et al., 1995; Nagel, 2002). It 
was shown that the fish embryo test was as or even more sensitive than the 
“Goldorfentest”. This led to the replacement of the “Goldorfentest” by the 
zebrafish D. rerio embryo test (D.I.N, 2003) in Germany, where it came into 
force the1st January 2005 (see Fig. 1-7). 
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Figure 1-7 Landmarks in zebrafish researches and applications 
 
1.3.3.2  Zebrafish D. rerio embryo assays in Toxicology 
1.3.3.2.1 DarT, a model for teratogenic assay 
  
The Danio rerio teratogenic assay, or DarT, was developed in 2000 
(Bachmann, 2002). 41 mammalian teratogens and non teratogens were 
evaluated with this model. From the 41 teratogenic and non-teratogenic 
substances tested, the results of 88% of the substances were in agreement with 
findings in mammals. From the left 12%, 4 were false positives (aceton, 2,5-
Hexandion, Isobutyl-ethyl-valproic acid and 1-Methoxy-2-propanol) and 2 were 
false negatives (salicylic acid and thalidomide). Even for teratogens requiring 
metabolic activation, malformations could be detected with DarT, however the 
effects, if any, were not as strong as assumed (Nagel, 2002).  
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1.3.3.2.2 Cardiotoxicity 
 
Cardiovascular effect is an important sublethal endpoint can be 
measured within DarT. It was shown that drugs known to provoke anomalies on 
the heart-beat were selected to investigate their effects on zebrafish embryos 
heart-beat. From these drugs, two were reducing and the other two were 
increasing the heart-beat frequence. For all the drugs, the results of the 
zebrafish embryo test were in concordance with their known mode of action. 
(Nagel, 2002; Zeller, 1995). 
 
1.3.3.2.3 Pigmentation 
 
Fish embryos are suitable to detect pigmentation toxicity. Pigmentation 
was found to be reduced in the zebrafish embryos by several anilines and 
phenols (Schulte, 1997). p-tert-Butylphenol which is known to influence the 
pigmentation in humans was also tested with the zebrafish embryos and gave 
similar results (Maiwald, 1997; Nagel, 2002).  
  
1.4 Toxicokinetics 
1.4.1 Principles 
 
 The fate of a xenobiotic in the human body can be characterized by 
the ADME (absorption, distribution, metabolism and excretion) scheme (see 
Fig. 1-8). If not injected directly into the circulation, a xenobiotic must be 
absorbed from an absorption site (e.g., gastrointestinal fluid or intramuscular or 
subcutaneous injection site). After entering the systemic circulation, the 
xenobiotic is distribute via the blood stream to the tissues and willl eventually 
reach its site(s) of action. To a certain extent, most xenobiotics become 
reversibly bound to plasma proteins and/or tissues constituents. A xenobiotic 
may be degraded by metabolism (biotransformation) and ultimately it is 
excreted from the body. During the ADME process, the xenobiotic has to 
permeate biological membranes. Xenobiotic cross membranes mainly by 
passive diffusion according to Fick’s law. Furthermore, it depends on the lipid 
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solubility of the substance in question. For an ionizable xenobiotic, lipid diffusion 
depends on its pKa value and the pH of body fluids (Fichtl, 1999). 
 
 
 
Figure 1-8 Schematic representation of the fate of a xenobiotic in the body (ADME 
scheme) (from Fichtl, 1999) 
  
 The two major excretion pathways in humans are via bile and via 
urine. For volatile compounds, exhalation can represent the dominant 
mechanism of excretion. In some cases, secretion into the mother’s milk may 
be of toxicological significance. 
 
 Both renal and biliary excretions require water-soluble substrates and 
become increasingly efficient with rising polarity of the compound to be 
excreted. While some xenobiotics are sufficiently water-soluble for excretion, 
many lipophilic components cannot be directly excreted and would accumulate 
if not biotransformed to more polar derivatives (see Fig. 1-9) (Oesch and Arand, 
1999). 
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Figure 1-9 Toxicokinetics (metabolism) (after Schobert, personal communication) 
 
 Enzymes involved in biotransformation are mostly located in the liver, 
which makes hepatic metabolism an important topic in drug discovery (Kumar 
and Surapaneni, 2001). However, other organs (e.g., lungs, kidneys, gut) also 
contain metabolizing enzymes. The reactions catalyzed by metabolizing 
enzymes are divided into two phases, Phase I and Phase II. 
  
 Phase I metabolic reactions are functional reactions, which usually 
introduce a polar functional group to a parent molecule to form a metabolite. 
The most common Phase I functional reactions include, but are not limited to, 
hydrolysis, reduction, and oxidation. The most important enzyme family in 
Phase I metabolism is the CYP family (Guengerich, 2003).  
 
 Phase II reactions are usually conjugating reactions, which conjugate a 
polar moiety to the parent compound or its Phase I metabolite. Therefore, the 
metabolites resulting from Phase II are usually much more polar and hydrophilic 
than the parent molecule, and are readily excreted from urine and/or bile. The 
common conjugation reactions for drugs are glucuronidation and sulfation as 
described in chapter 1.4.3. 
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1.4.2 Phase I enzyme systems 
1.4.2.1 Cytochrome P450s 
 
 Cytochrome P450s (CYPs) are the most important drug metabolizing 
enzymes for numerous xenobiotics (e.g., drugs, agricultants, pollutants and 
dietary components) as well as some endogenous substrates (e.g., bile acids, 
steroids, and cholesterol) in animals and humans. CYP enzymes are present in 
many mammalian organs, such as kidneys, lungs and intestines with the 
majority in the liver. Structurally, CYPs are hemoproteins composed of the 
coenzyme protoporphyrin IX and a variable moiety of ca. 50kDa (Testa and 
Krämer, 2007). 
 
 Based on amino acid sequence homology, CYP superfamily members 
are divided into various subfamilies, which are further divided into various 
isoforms. More than 25 CYPs subfamilies are currently identified and only four 
subfamilies (i.e., CYP1, CYP2, CYP3 and CYP4) are defined as drug 
metabolizing enzymes. Major isoforms involved in the biotransformation of 
xenobiotics in humans are CYP1A2, CYP2C9, CYP2C19, CYP2D6, 
CYP2E1and CYP3A4 (Fig. 1-10) (Guengerich, 2008). Among these isoforms, 
CYP3A4 is the most abundant isoform and accounts for approximately 30 to 
40% of the total CYPs content in human liver and small intestine. CYP3A4 is 
estimated to metabolize between 50-70% of the currently used drugs. CYP 
isoforms exhibit significant substrate specificity during the biotransformation 
process, such as regio- and stereo- selectivity. Furthermore, CYP enzymes can 
be inhibited, as well as induced by several specific xenobiotics, which possess 
the potential for drug-drug interactions (Lin et al., 2003). 
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Figure 1-10 Contribution of the major human Cytochrome P450s to the Phase I 
metabolism of all drugs currently marketed (Guengerich, 2003) 
 
 The generally accepted catalytic cycle for CYP reactions is shown in 
Fig. 1-11. However, the point should be made that this is a simplified version 
and that the system is dynamic, and the steps do not necessarily proceed in a 
linear order around the cycle. Moreover, rate-limiting steps in CYP reactions 
probably vary considerably, depending upon the reaction and the in vitro 
experimental setting (Guengerich, 2008). 
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Figure 1-11 Basic Cytochrome P450 cycle (Guengerich, 2008) 
  
1.4.2.2 Epoxides Hydrolases 
 
 Epoxides hydrolases (EHs) are a group of functionally related 
enzymes that catalyse the hydrolytic cleavage of oxirane rings. The two 
mammalian EHs with implication for xenobiotic metabolism are microsomal 
epoxide hydrolase (mEHs) (see Fig. 1-12) and soluble epoxide hydrolase 
(sEH). mEHs are known to be involved in the biotransformation of 
benzo[a]pyrene and are strongly expressed in animal and human livers 
(Prestwich et al., 1985).  
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Figure 1-12 Schematic representation of the orientation of cytochrome P450 and its 
reductase, microsomal epoxide hydrolase, and glucuronyl transferase in 
the smooth endoplasmic reticular membrane. (Park et al., 1995) 
 
1.4.2.3 Flavin containing Monooxygenases 
 
Flavin Monooxygenases (FMOs) are a gene family of five enzymes 
(FMO1 to FMO5) involved in the metabolism of numerous nucleophilic 
heteroatom-containing xenobiotics (e.g., N-, S-, P-) (Cashman, 1995). Among 
the five FMO isoforms, FMO3 is found primarily in human liver (Ziegler, 1993), 
(Tynes and Philpot, 1987). Like CYPs, FMOs (i) are primarily localized in the 
endoplasmic reticulum, (ii) require the coenzyme NADPH and molecular oxygen 
for activity and (iii) are found in all mammalian species in nearly all tissues 
(Halpert et al., 1998), but primarily in livers. Species differences and genetic 
polymorphism in FMO activities are exhibited (Ziegler, 1998). Since CYPs have 
the similar capability to metabolize nucleophilic heteroatom-containing 
molecules, the differentiation of the oxidation activity between FMOs and CYPs 
can be achieved by chemical inhibitors, heat sensitivity (Mushiroda et al., 2000), 
and recombinant isoforms (Lin et al., 2003). 
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1.4.3 Phase II enzyme systems 
1.4.3.1 UDP-Glucuronosyltransferases 
 
UDP-Glucuronosyltransferases (UGTs) are a superfamily of membrane-
bound enzymes that catalyze the transfer of α-D-UDP-glucuronic acid (UDPGA) 
to a large number of endogenous compounds and xenobiotics to form 
glucuronide metabolites (Fig. 1-13) (Cashman et al., 1996). In most cases, 
glucuronic acid conjugation substancially increases the hydrophilicity of a 
substrate and favouring its excretion.  
 
UGTs can be divided into two families (UGT1 and UGT2) and are 
resident proteins of the ER with the orientation of the catalytic center towards 
the ER lumen. When in vitro UGTs-catalyzed reactions are performed with liver 
microsomes, permeabilization of the membranes with detergent is required to 
give the enzyme free access to its substrate and cofactor. 
 
Figure 1-13 Conjugation of a nucleophile (i.e., R-X-H) with α-D-UDP-glucuronic acid to 
form the glucuronidation metabolites (Lin et al., 2003) 
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1.4.3.2 Sulfotransferases 
 
Sulfotransferases (STs) are dimeric enzymes that biotransform many 
drugs and xenobiotics by sulfation to more hydrophilic metabolites readily 
excreted from the body (Fig. 1.14). PAPS (3’-Phosphoadenosine 5’-
phosphosulfate) is the “sulfate donor” for STs during the biotransformation. STs 
are either cytosolic or microsomal, however the most common STs involved in 
Phase II metabolism for drugs and xenobiotics are located in cytosol (Lin et al., 
2003). 
 
Figure 1-14 Sulfation catalyzed by Sulfotransferases (Lin et al., 2003)  
 Legend: ST: sulfotransferase; PAPS: 3’-Phosphoadenosine 5’-
 Phosphosulfate; PAP: 3’-Phosphoadenosine 5’-Phosphate. 
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1.4.4 In Vitro systems 
1.4.4.1 Overview 
 
Since hepatic and extra-hepatic metabolism represents a major 
biotransformation pathway for xenobiotics, extensive efforts are made to 
thoroughly investigate their metabolism during development phases (Hariparsad 
et al., 2006). Therefore, in vitro models containing Phase I and/or Phase II 
enzyme systems were developed. Figure 1-15 summarizes the hierarchy of 
resemblance between the in vivo situation with the in vitro models.  
 
Resemblance on true
in vivo situation
Ethically acceptable
Easy applicable
Complexity
 
 
Figure 1-15 In vitro and in vivo model used in the development of new drugs, ranging 
from human to isolated enzymes, in order to in vivo resemblance (Brandon 
et al., 2003) 
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1.4.4.2 Sub cellular fractions 
1.4.4.2.1 Liver Microsomes 
 
Liver microsomes are small membranous vesicles derived from the ER of 
hepatocytes as a result of tissue homogenization and are isolated by 
ultracentrifugation (Fig. 1-16). The microsomal fraction consists of membranous 
vesicles with free ribosomes, glycogen granules, and fragments of other 
subcellular structures such as mitochondria and Golgi apparatus and also 
contain CYPs, FMO, mEHs and UGTs. Their activity can be measured by 
various model substrates (Hodgson and Levi, 1997).  
 
Liver microsomes account for the most popular in vitro model, providing 
an affordable way to give a good indication of the CYPs and UGT metabolic 
profile. Also, the influence of specific isozymes can be studied in the presence 
of specific inhibitors (Birkett et al., 1993). NADPH regenerating system (NRS) or 
NADPH is required to supply the energy demand of the CYPs and FMOs. 
Similarly, UGTs require UDPGA and alamethicin for activity.  
 
 
 
 
Figure 1-16 Isolation of microsomes from primary hepatocytes (Cooper, 2000) 
 
Microsomes can be prepared from all species such as rats or humans: 
 
Human liver microsome activities can vary substantially between 
individuals. This issue, however, can be successfully solved by the application 
of pooled microsomes, which results in a representative enzymatic activity 
(Araya and Wikvall, 1999). Individual human liver microsomes can also be used 
to screen for the interindividual variability of the biotransformation of a drug. It is 
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also possible to identify the critical CYP involved in the biotransformation of a 
drug using individual human liver microsomes by correlating the enzyme activity 
of a particular CYP, using a bank of human donors, to the metabolism of the 
drug. The influence of gender on drug biotransformation can be investigated 
with gender-specific human liver microsomes pools (Brandon et al., 2003).  
 
Different animal liver microsomes (e.g., mouse, rat, monkey) are 
available. The CYPs content can be artificially raised in animal livers using 
general inducing agents. This raise is obtained by treating laboratory animals 
with prototypical CYPs enzymes inducers (see Table 1-2) before collecting the 
animal liver.  
 
 The induction mechanism involves synthesis of new enzyme at the 
transcriptional or post-transcriptional level. The effects of inducers on the 
metabolic activity of hepatic microsomes subsequently isolated from treated 
animals have often been reported. Although, the comparison with the in vivo 
situation is modified, the specificity and the sensitivity can be tremendously 
enhanced (Hodgson and Levi, 1997). 
  
Table 1-2 Inducing agents of CYPs in rats 
 
 CYP 
1A1/1A2 
CYP 
2B1 
CYP 
3A4 
CYP 
2E1 
β-Naphthoflavone +    
Phenobarbital  +   
Dexamethasone   +  
Isoniazid    + 
β-Naphthoflavone & Phenobarbital + + + + 
Aroclor1254 + + + + 
 
  
 The major advantage of microsomes is their simplicity in use. They are 
well-characterized in vitro systems for drug biotransformation research. 
However, some drawbacks exist. First, it should be noted that results obtained 
with microsomes must be extrapolated, because these enzymes are enriched in 
the microsomal fraction and there is no competition with other enzymes. This 
results in higher biotransformation rates in microsomes compared to the in vivo 
situation, but also compared to other in vitro systems (Sidelmann et al., 1996). 
Additionally, the absence of other enzymes (e.g., Phase II enzymes: 
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acetyltransferase (AT), glutathione S-transferase (GST) and STs) and cytosolic 
cofactors can leave metabolites formed in intact liver cells unnoticed 
(Crommentuyn et al., 1998). 
 
1.4.4.2.2 Cytosolic fraction 
 
 The liver cytosolic fraction contains the soluble Phase II enzymes, e.g., 
AT, GST, and STs. It is obtained by differential centrifugation of whole-liver 
homogenate. For the catalytic activity of the Phase II enzymes, supplementation 
of exogenous cofactors is necessary, e.g., acetyl coenzyme A (acetyl CoA) for 
AT, PAPS for ST, and glutathione (GT) for GST. 
 
 The main characteristic of this system is the presence of only three 
enzymes in the cytosolic fraction at higher concentrations compared to liver S9-
mix. The biotransformation capacity of AT, ST, and GST can be studied 
separately or in combination depending on the cofactors added (Brandon et al., 
2003).  
 
1.4.4.2.3 S9-mix 
 
 The liver S9-mix contains both microsomal and cytosolic fractions. 
Similar to microsomes, a NRS or NADPH solution is required to supply the 
energy demand of the CYPs and FMOs. For the catalytic activity of Phase II 
enzymes, addition of exogenous cofactors is also necessary. S9-mix is used for 
genotoxicity testing such as the Ames test, which is a simple and rapid in vitro 
method for detecting the mutagenicity of chemicals (Maron and Ames, 1983). 
 
 Compared with microsomes and cytosol, S9-mix offers a more 
complete representation of the metabolic profile, as it contains both Phase I and 
Phase II activities. However, a disadvantage is the overall lower enzyme activity 
in the S9-mix compared to microsomes or cytosol, which may leave some 
metabolites unnoticed. 
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1.4.4.3 Cell cultures 
 
Primary hepatocytes are a popular in vitro system for drug 
biotransformation research due to their strong resemblance of in vivo liver. 
Detailed reviews dealing with this model have been published previously (Hewitt 
et al., 2007). Hepatocytes of various animal species can be isolated from the 
liver by collagenase perfusion (Howard et al., 1967). However, this method is 
not applicable for human hepatocytes. Therefore, a method for human liver 
parts has been developed (Guyomard et al., 1990).  
 
 Once isolated, hepatocytes can be held viable in suspension for only a 
few hours, or they can be maintained in monolayer culture for a maximum of 4 
weeks. Both, cultured hepatocytes (Chenery et al., 1987) and suspensions of 
primary hepatocytes (Bayliss et al., 1999) have repeatedly proven to be 
powerful tools to analyze the specific metabolic profile of a variety of drugs with 
good in vitro–in vivo correlations (Bayliss et al., 1999) (see Fig 1-17).  
 
 However, it has been widely recognized that cultured hepatocytes are 
subject to a gradual loss of liver-specific functions, with special reference to a 
decreased CYP expression. This loss is different for the specific CYP isoforms; 
for some isoforms it becomes evident after a few days of culture (CYP 2E1 and 
CYP 3A4), while others remain nearly unaffected by the isolation and culturing 
processes (CYP 1A2 and CYP 2C9) (George et al., 1997). 
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Figure 1-17 Primary rat hepatocytes in monolayer cell culture after 48 h (Tuschl, G., 
personal communication) 
 
 Advantageous of isolated hepatocytes is the possibility of 
cryopreservation. Cryopreserved hepatocytes have been shown to retain the 
activity of most Phase I and Phase II enzymes (Silva et al., 1999) and are now 
commercially available. Due to their widespread use in drug biotransformation 
research, isolated hepatocytes have become a well-established and well-
characterized in vitro model and, with special techniques, isolated hepatocytes 
can be made viable for up to 3 weeks (Tuschl, G., Personal communication - 
see Fig. 1-18). However, it should be noted that prolonged culture conditions 
result in a more complex data interpretation, since outcomes partly depend on 
culture system factors.  
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Figure 1-18 Primary rat hepatocytes in sandwich culture without serum after 2 weeks 
(Tuschl, G., personal communication) 
  
 Primary hepatocytes are well characterized, contain both Phase I and 
II and are viable for few weeks under specific culture conditions. However, this 
in vitro model is extremely lab-intensive and there is considerable interindividual 
variation with human hepatocytes. Nevertheless, this can be overcome by using 
mixtures of hepatocytes from multiple donors to mimic average enzyme content 
(Brandon et al., 2003). 
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1.4.4.4 Liver slices 
 
 Cultures of tissue slices were developed in the 1920s by Otto Heinrich 
Wartburg. Today, the incubation of liver slices in nutrient enriched media offers 
a powerful tool to study biotransformation in vitro. The development of high-
precision tissue slicers set the stage for the “renaissance” of liver slices in in 
vitro biotransformation studies. The thin slices obtained (250 µm thickness) with 
the Krumdieck and the Brendel-Vitron slicers realistically and reliably represent 
the in vivo situation and have been used to study the biotransformation of many 
compounds (Ekins, 1996). However, the difficulties of long-term storage of liver 
slices complicate their commercialization. Dynamic organ culturing (DOC) was 
developed to prolong the limited viability period of liver slices. In this technique, 
the slice is continuously exposed to both culture medium and gas atmosphere 
(Smith et al., 1985a). Some variants of DOC were developed later (Olinga et al., 
1997).  
 One main advantage of liver slices is the nonrequirement for digestive 
enzymes and thus the intact cellular tissue architecture, allowing for 
biotransformation studies in nonhepatocytes. Another main advantage is the 
possibility to study the induction of CYPs isoforms by new drugs.  
 
The most prominent disadvantages include inadequate penetration of the 
medium into the inner part of the slice, damaged cells on the slice outer edges 
with impaired biotransformation, and the short viability time period of 5 days. 
Also, the optimal incubation method is highly dependent on the applications of 
the liver slices. All in all, tissue slice cultures are a powerful tool to study 
biotransformation in vitro, but the drawbacks mentioned still prevent its large-
scale application (Brandon et al., 2003).  
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1.5  Test materials 
1.5.1 Cyclophosphamide 
 
N
ClCl
P
O NH
O
 
Figure 1-19 Cyclophosphamide hydrate CAS#: 6055-19-2 
1.5.1.1 Physicochemical Properties 
 
 Cyclophosphamide (CPA) (Fig. 1-19) is an odorless, fine white 
crystalline powder with a molecular weight of 279.1 g/mol. It is soluble in water 
and ethanol. Its LogK(O/W) is 0.63. CPA reacts with strong oxidizing agents, is 
sensitive to moisture and light and is hydrolyzed in aqueous solutions above 
30°C. 
 
1.5.1.2 Application and mode of action 
 
 CPA is an alkylating antineoplastic agent that acts against a wide 
variety of oncologic and nononcologic conditions (e.g., transplantation 
prophylaxis, severe rheumatoid disorders) in various therapeutic categories. 
The drug prevents cell division by cross-linking DNA strands and decreasing 
DNA synthesis. It is cell-cycle-phase nonspecific. The mechanism by which this 
occurs is apparently through its metabolites phosphoramide mustard and 
acrolein (Schardein and Macina, 2007). 
 
 Since the parent drug shows no cytotoxicity, it requires bioactivation 
(Fig. 1-20) via ring oxidation by CYPs to finally yield the alkylating metabolite 
phosphoramide mustard and the acrolein (Bohnenstengel et al., 1996). 
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Figure 1-20 Metabolism of cyclophosphamide. The inactivation pathways are depicted 
horizontally, while cyclophosphamide activation is shown vertically. (De 
Jonge et al., 2005). 
 
1.5.1.3 Developmental toxicity 
 
 In in vivo teratogenicity studies (e.g., mice, rats, rabbit, primates), CPA 
elicited a full spectrum of developmental toxicities including multiple 
malformations (growth retardation and exencephaly). In humans, a specific 
syndrome of defects was identified to include congenital malformations of the 
digit, palate, ears, face, skin and in some cases the skull was affected (see Fig. 
1-3) (Schardein and Macina, 2007). 
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1.5.2 Ethanol 
 
 
Figure 1-21 Ethanol CAS#: 64-17-5 
 
1.5.2.1 Physical and Chemical Properties 
 
 Ethanol is a colorless versatile solvent (Fig. 1-21), miscible in all 
proportions with water, some organic solvents and light aliphatic compounds 
and has a molecular weight of 46.07 g/mol. Its LogK(O/W) is -0.30. 
 
1.5.2.2 Application and mode of action 
 
 Ethanol acts as a central nervous system depressant with intoxicating 
properties (Schardein and Macina, 2007).  
 
 Alcohol-induced oxidative stress is linked to the metabolism of ethanol. 
Three metabolic pathways of ethanol have so far been described in the human 
body, which involve the following enzymes: alcohol dehydrogenase (Fig. 1-22), 
microsomal ethanol oxidation system (Fig. 1-23) and catalase (Fig. 1-24). Each 
of these pathways could produce free radicals that affect the antioxidant system 
(Das and Vasudevan, 2007).  
 
 The classical pathway of ethanol metabolism, which is catalysed by 
alcohol dehydrogenase to form acetaldehyde results in the formation of free 
radicals (Fig. 1-22). 
 
 
 
Figure 1-22 Alcohol Dehydrogenase mode of action with ethanol (Das and Vasudevan, 
2007) 
 
 The microsomal electron transport system also participates in ethanol 
oxidation via catalysis by the CYP isoenzymes. The enzymes in this family 
CH3CH2OH + NAD+ CH3CHO + NADH + H+ 
C2H5OH 
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include the 2E1, 1A2 and 3A4 isoforms, which vary in their capacity to oxidize 
ethanol (Fig. 1-23). 
 
 
Figure 1-23 CYPs mode of action with ethanol (Das and Vasudevan, 2007) 
 
 Peroxisomal activity also contributes to ethanol oxidation in the liver 
(Fig. 1-24). 
 
 
Figure 1-24 Catalase mode of action with ethanol (Das and Vasudevan, 2007) 
 
1.5.2.3 Developmental toxicity 
 
 Laboratory animal studies (e.g., mouse and rat) clearly demonstrated 
potent developmental toxicity after ethanol administration, with defects in 
craniofacial development being the most predominant.  
 
 The developmental toxicity associated with ethanol was first 
documented in human foetuses in 1968. Fetal Alcohol Syndrome (FAS) was 
rediscovered in 1973 by Jones and Smith and refers to a pattern of defects in 
the offspring of alcoholic women consisting of pre- and postnatal growth 
deficiency, physical malformations, motor dysfunction and mental retardation 
(Abel and Dintcheff, 1978). The most typical abnormalities are associated with 
the central nervous system, craniofacial development, cardiac system and the 
skeleton (see Fig. 1-2) (Schardein and Macina, 2007). 
 
RCH    CHCOSCoA  + H2O2 RCH2CH2COSCoA + O2 
AcylCoA oxidase 
CH3CH2OH + H2O2 Catalase CH3CHO + 2 H2O 
CH3CHO + NADP+ + 2 H2O CH3CH2OH + NADPH + H+ + O2 
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1.5.3 Benzo[a]pyrene 
 
 
 
Figure 1-25 Benzo[a]pyrene CAS#: 50-32-8 
 
1.5.3.1 Physicochemical Properties 
 
 Benzo[a]pyrene (B[a]P) (Fig. 1-25) is a member ubiquitously 
distributed in organic compounds known as polycyclic aromatic hydrocarbons 
(PAHs). It is a crystalline powder with a molecular weight of 252.3 g/mol. B[a]P 
is practically insoluble in water (max. 10 nM at 25°C) and very lipophilic 
(LogK(O/W) = 6). B[a]P is sensitive to light. 
1.5.3.2 Application and mode of action 
 
 B[a]P as a product of incomplete combustion - at temperatures 
between 300 and 600°C - is present in tobacco smoke, polluted air and in 
contaminated food and water. 
  
 The ultimate carcinogens arising from the metabolic activation of B[a]P 
are stereoisomers of B[a]P 7,8-diol-9,10-epoxide (Fig. 1-26). These metabolites 
arise by prior formation of the 7,8-epoxide, which gives rise to the 7,8-
dihydrodiol through the action of EHs. This is further metabolized by the CYPs 
to the 7,8-diol-9,10-epoxides, which are both potent mutagens and unsuitable 
substrates for the further action of the EHs. Stereochemistry is important in the 
toxicity of the final product. Of the four possible isomers, the (+)-B[a]P diol 
epoxide-2 is the most active carcinogen (Hodgson and Levi, 1997).  
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Figure 1-26 Schematic representation of the metabolism of bento[a]pyrene into the 
carcinogenic 7,8-dihydrodiol 9,10-epoxide by mEh and CYP P450. (Lin et 
al., 2003).  
Legend: mEH: microsomal epoxide hydrolase; P450; Cytochrome P450. 
 
1.5.3.3 Developmental toxicity 
 
 B[a]P has been shown to be carcinogenic to experimental animals. 
Moreover, B[a]P is embryotoxic and teratogenic in mice; the inducibility of aryl 
hydrocarbon hydrolase activity in dams and foetuses is an important factor in 
determining these effects. A reduction in fertility in both male and female 
offspring was observed in mice following exposure to B[a]P in utero (Shepard 
and Lemire, 2004). 
  
 There is no data available to reference B[a]P as a human teratogen. 
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1.5.4 Thalidomide 
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Figure 1-27 Thalidomide CAS#: 50-35-1 
 
1.5.4.1 Physicochemical Properties 
 
 α-Phtalimidoglutarimide or thalidomide (Thal) (Fig. 1-27) is a neutral 
racemic compound derived from glutamic acid. It consists of R- and S- 
enantiomers. Thal is a white crystalline powder sparingly soluble in water (< 0.1 
g/L) with a LogK(O/W) of 5.0. It is stable in the solid form but spontaneously 
hydrolyses in solution at pH 6.0 or higher to produce at least 12 hydrolysis 
products. It is stabilized in aqueous media through acidification (Teo et al., 
2004). 
1.5.4.2 Application and mode of action 
 
 Thal is a widely known agent that when introduced into the market 
place in Europe almost 50 years ago, was promoted as a sedative. It was useful 
for treating nausea and vomiting of pregnancy and was said to be effective 
against influenza. Following removal from the market globally in 1962 due to the 
discovery of its ability to cause human birth defects mainly limb reduction 
malformation (phocomelia – see Fig. 1-1), it was reintroduced in July 1998 as 
an immunomodulator, for therapeutic use in the treatment of erythema nodosum 
leprosum (ENL; a serious inflammatory condition of Hansen’s disease) and in 
orphan status for treating Crohn’s disease (ongoing disorder that causes 
inflammation of the digestive tract) and a few other indications (Schardein and 
Macina, 2007) 
 Although much careful work has been done in an attempt to 
understand the mechanism of action, the reason for the chemical and species 
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specificity remains a pharmacologic riddle. Many hypotheses have been 
suggested such as (i) DNA-intercalating pathway or (ii) disruption mechanism in 
angiogenesis or (iii) expression inhibition of adhesion receptors (D'amato et al., 
1994; Neubert et al., 1996). 
 
1.5.4.3 Developmental toxicity 
 
 Thal effects are species specific. On the one hand, some species such 
as dog, cat, rabbit and monkey were sensitive to Thal and displayed concordant 
malformations (limb). The most sensitive species to Thal are three primates 
species (the baboon, the stump-tailed monkey and the bonnet monkey) all of 
which showed developmental toxicity at a dose of 5 mg/kg/day (Hendrickx and 
Newman, 1973). On the other hand laboratory species such as rats and mice 
were the least sensitive. Indeed, with mice (A and Swiss strains) (Dipaolo, 
1963) and rats (Sprague-Dawlley and Wistar strains) (King and Kendrick, 1962), 
Thal elicited embryolethality, growth retardation and nonconcordant 
malformations at a dose level of ≈ 30 mg/kg. In contrast, rabbits were more 
responsive to Thal than the other rodents and elicited concordant (limb) 
malformations and embryolethality at 25 mg/kg (Staples and Holtkamp, 1963). 
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2 Aims and objectives 
  
 Zebrafish D. rerio embryos are routinely used as a teratogenic 
screening test, namely DarT. However fish eggs lack biotransformation in early 
embryonic stages. To fill this gap, we combined zebrafish D. rerio embryos with 
an exogenous metabolic activation system (MAS) and tested this model to 
prototypical proteratogenic compounds (test materials). 
 
To reach this aim, three possible models were considered. 
 
• The direct co-culture model 
 
 The direct co-culture model (see Fig. 2-1) involves a close contact of 
fish eggs with a MAS together with the test material. The advantage of this 
model is that it  allows high reactive, often unstable, new metabolites a direct 
and prompt contact with fish embryos (Hodgson and Levi, 1997). However, 
there are different incubation conditions for fish eggs and MAS (see chapter 
4.1.1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1 The direct co-culture model with the fish embryo, a metabolic activation 
system and the test material.  
 Legend: blue: buffer; yellow: microsomes; green: test material; red: reactive 
metabolite.  
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• The indirect co-culture model 
 
 As displayed in Figure 2-2, in the indirect co-culture, the well is divided 
into two compartments separated by a semi-permeable membrane. This model 
could reduce a possible toxicity of MAS to fish eggs. However one must 
consider the short-lived metabolites of products and the different incubation 
parameters for the fish eggs and MAS (see chapter 4.1.1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2 The indirect co-culture model with the fish embryo, a metabolic activation 
system and the test material. 
 Legend: blue: buffer; yellow: microsomes; green: test material; red: reactive 
metabolite. 
 
• The three-step model 
 
 The three-step model (see Fig. 2-3) consists of three phases, namely 
(i) incubation of test material with MAS; (ii) extraction of metabolite(s) from 
MAS; and (iii) exposure of metabolite(s) with fish eggs for 48 hours. Although, 
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incubation requirements for fish eggs and MAS are optimal, extraction of new 
metabolite(s) could be a limiting-step due to their unstability. 
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Figure 2-3 The three-step model with the fish embryo, a metabolic activation system and 
the test material.  
Legend: blue: buffer; yellow: microsomes; green: test material; red: reactive 
metabolite. 
  
 From, these three models, the direct co-culture would be favourite as it 
is the only one that (i) allows a close contact of fish embryos with MAS and the 
test material during the whole incubation time and (ii) would be easy to handle. 
Therefore, the direct co-culture seems the most appropriate model. 
 
The choice of the in vitro metabolic activation system (e.g., subcellular 
fractions, cell culture) is made considering its ability (i) to have a low toxicity for 
fish eggs and (ii) to be easy to handle and to obtain. 
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 Subcellular fractions, respectively S9-mix and microsomes from rat 
liver would be the most probable activation mechanism to be included in the 
direct co-culture model. Even though they are not as complex as cell culture, 
they are very easily applicable and have a high Phase I and II enzymes content. 
Moreover, as a simple model, the incubation conditions for metabolic activity 
are more flexible compared to cell culture. Although S9-mix contain Phase I and 
II, its toxicity was previously reported when combined with cell cultures 
(Jorgensen et al., 2004). This could irreversibly damage fish embryo 
development. Therefore, rat liver microsomes were chosen as the metabolic 
activation system. 
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3 Materials and Methods 
3.1 Equipment and Materials 
 
Animal Care  
Cyclop-eeze ® (aquatic nutrient) Argent Laboratories, U.S.A. 
TetraMin ® (aquatic nutrient) Tetra-GmbH, Germany 
Aquarium (Glass, silicon sealed, 80 l) Zoo-Markt Meyer, Darmstadt, Germany  
Pump Zoo-Markt Meyer, Darmstadt, Germany 
Foam insert (Fluval ® “1Plus”) Art.# A-180 Hagen, Germany  
Air diffuser (Hobby ® 30 x 15 x 15 mm) DOHSE aquaristik KG, Germany 
Boxes  Kunstoffwerkstatt Merck KGaA, Germany 
  
Equipement  
Precision incubator, model INE 500 Memmert GmbH & Co. KG, Germany 
Precision balance, Sartorius, model BP211D Sartorius AG, Germany 
Balance Navigator OHAUS GmbH, Germany 
Laboratory pH-meter, 766-Knick Elektronische Messgeräte GmbH & Co, 
Germany 
Magnetic stirrer, IKAMAG ® 2 KMO2 Basic IKA®-Werke GmbH & Co.KG, Germany 
Shaking water bath - 1092 GFL-mbH, Germany 
Vortex-Genie 2 ® Scientific industries, U.S.A. 
Water bath - 1002 GFL-mbH, Germany 
Stereo microscope Zeiss, Germany 
Inverted microscope, CKX41 Olympus, U.S.A. 
Software analySIS Olympus, U.S.A. 
Software Origin ® 7.0 SR0 v 7.0220 (B220) OriginLab Corporation, U.S.A. 
Software Adobe ® Photoshop ®  
  
  
Metabolic Activation System  
NADPH, Cat No: N1630 Sigma, U.S.A. 
NADPH Regenerating System Solution A & B GENTEST, U.S.A. 
Hydrochloric Acid, 1.09063.1000 Merck KGaA, Germany 
Tris(hydroxymethyl)-aminomethan, 1.08382.0100 Merck KGaA, Germany 
  
Test materials  
Cyclophosphamide monohydrate, Cat No: 239785 Calbiochem, Germany 
Thalidomide, Cat No: T 144 SIGMA, U.S.A. 
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Benzo[a]pyrene, Cat No: 48564 SUPELCO, U.S.A. 
Ethanol, 1.11727.4000 Merck KGaA, Germany 
DMSO, Cat No: D 2650 
3-Aminobenzoic acid ethyl ester (MS-222),  
Cat No: A5040 
SIGMA, U.S.A. 
SIGMA, U.S.A. 
DMEM/F12 Serum, Cat No: 11330-032 GIBCO, Germany 
Protein Inhibitor Cocktail set III, Cat No: 539134 Calbiochem, Germany 
Titriplex® III, Cat No: 1.08418.0250 Merck KGaA, Germany 
  
Microsomes (XenoTech, LLC, U.S.A.) 
Male Sprague Dawley Rat Liver Microsomes, Phenobarbital and β-Naphthoflavone-treated 
 rats, R1081 
Male Sprague Dawley Rat Liver Microsomes, Phenobarbital-treated rats, R 1078 
Male Sprague Dawley Rat Liver Microsomes, β-Naphthoflavone-treated rats, R 1083 
Male Sprague Dawley Rat Liver Microsomes, Isoniazid-treated rats, R 1088  
Male New Zealand Rabbit Liver Microsomes, L 1000 
 
Microsomes (Celsis - In Vitro Technologies, Inc, U.S.A.) 
Sprague Dawley Rat Liver Microsomes; Aroclor1254-treated. M 10001 
Sprague Dawley Rat Liver Microsomes; Isoniazid-treated. M 50001 
Sprague Dawley Rat Liver Microsomes; β-Naphthoflavone-treated. M 20001 
  
Laboratory Glass Ware  
Petri Dishes (Ø 185 mm) VWR, Germany 
Test tubes (Ø 16 mm) VWR, Germany 
Amber Vial (1, 5, 10 ml)   VWR, Germany 
Graduated cylinder (50, 500 ml) VWR, Germany 
  
Disposables  
24-well plates Nunc GmbH, Germany 
Pasteur pipette non sterile graduated (3 ml) VWR, Germany 
Polypropylene test tubes (Ø 16 mm) BD Biosciences, Germany 
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3.2 Test Organism 
3.2.1 Origins 
 
Species:  Parents: Zebrafish, D. rerio, originated from West-Aquarium 
 Test organisms: Embryos of D. rerio 
 
Breeder:  Institute of Toxicology, Merck KGaA  
3.2.2 Animal care and egg production 
 
 A breeding stock of unexposed and healthy mature zebrafish older 
than 6 months was used for egg production. Spawners were maintained in 
aquaria with a loading capacity of a minimum of 1 L water per fish. Lighting was 
controlled by a timer to provide a 12-hour-light and 12-hour-dark regime. 
Females and males were continuously held together in a ratio of 1:2. Dry flake 
food was fed twice a day and live food (white mosquito larvae) was fed once a 
day (O.E.C.D., 2006; Westerfield, 2000).  
 
 Mating and spawning took place within 15 min after turning on the 
lights in the morning. To prevent adult zebrafish from egg predation, egg traps 
were covered with a stainless steel mesh with a grid size of 2 mm. Plastic plant 
imitations serving as spawning substrate were fastened onto the mesh. About 
20-30 min after the onset of light the egg traps were removed and the eggs 
were collected (O.E.C.D., 2006). At 26°C, fertilized eggs undergo the first 
cleavage after approximately 15 min and consecutive synchronous cleavages 
form 4, 8, 16, and 32 cell blastomeres. At these stages (4-32 cells) eggs can be 
identified clearly as fertilized and only these were used for further 
experimentation (Nagel, 2002; Schulte and Nagel, 1994). 
 
Materials and Methods 
49 
3.3 Fish Embryo Assay with Metabolic Activation (mDarT) 
3.3.1 Standard protocol 
3.3.1.1 Temperature 
 
 The optimal temperature of mammalian microsomes is 37°C. In 
contrast, fish embryos develop optimally at a temperature of 26-28.5°C. 
However, they tolerate an eight degree range, between 25°C and 33°C. 
Incubating them for long periods above or below these extremes may produce 
abnormalities (Braunbeck et al., 2005; Kimmel et al., 1995). Thus, mammal 
microsomes were incubated at 32°C to achieve the highest metabolic activation 
together with normal fish embryo development. 
 
3.3.1.2 Fish medium 
 
 As fish medium (FM), reconstituted water was used in accordance with 
the DIN 38415-6. Fish medium composition is summarized in Table 3-1. 
  
Table 3-1 Fish medium composition 
 
Salts composition Concentration [mM] 
CaCl2 * 2 H2O 2 
MgSO4 * 7 H2O 0.5 
NaHCO3 0.7 
KCl 0.07 
 
 These salts are indispensable for correct functioning of Na+/K+ and 
Mg2+/Ca2+ ions pump for zebrafish embryos osmolarity equilibrium. The 
proportion Ca2+:Mg2+ is 4:1 and Na+:K+ ions is 10:1. The pH was kept between 
6.8 and 8.0. The fish medium was aerated to oxygen saturation and was kept 
above 80%. 
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3.3.1.3 Metabolic activation system 
 
 Tris was dissolved in fish medium and neutralized with HCl. Tris-HCl 
buffer concentration was 0.1 M, pH 7.6 at 25°C to achieve pH 7.4 at 32°C. 
Microsomes vial was thawed at 25°C in a water-bath for 5 min. Thereafter 
microsomes were diluted in Tris-buffer to an induced rat liver microsomal 
protein final concentration of 0.7 mg/ml assayed by the Bicinchoninic Acid 
(BCA) protein assay (Smith et al., 1985b). NADPH stock solution was dissolved 
in Tris-buffer to a final concentration of 1 mM. The end volume of MAS was 
2000 µl. 
 
3.3.1.4 Exposure of the eggs 
3.3.1.4.1 Study design 
 
 For each test material a concentration range finding experiment was 
conducted (three to four concentrations) with a constant spacing factor of 2. In 
general, two controls were used in each experiment: (i) a negative control 
consisting of the highest concentration of the proteratogen without MAS and (ii) 
the MAS control consisting of the MAS alone. For protocol details, see Annex A. 
Typically, twenty fish embryos were used per concentration group.  
3.3.1.4.2 Eggs selection 
 
 Fish embryos were washed twice in glass Petri dishes with the Tris-
buffer (Fig. 3-1). Within the first hour post fertilization, the fecundated fish 
embryos (from 4 to 32 cell blastomeres - Fig. 1-6A) were sorted under a 
stereomicroscope and collected in a plastic Petri dish containing Tris-buffer. 
From the pooled fecundated fish embryos, twenty eggs were randomly 
transferred into a 2 ml vial for each group. All these steps were performed at 
26°C.  
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 Figure 3-1 DarT with a Metabolic Activation system: mDarT; Eggs exposure. (Busquet et 
al., 2008). 
Legend: TM: test material; MAS: Metabolic Activation System; hpf: hours post 
fertilization. 
 
 For cyclophosphamide and ethanol, MAS was prepared in a 
polypropylene test tube stored on ice, filled with Tris-HCl buffer (0.1 M), 
microsomes and the test material (i.e., premix). NADPH was weighted in a 
brown glass, dissolved with Tris-HCl buffer and stored on ice.  
  
 A 5 min preincubation step was performed at 32°C and 100 rpm for the 
test tubes containing the premix and the NADPH stock solution (10 mM). 
Afterwards, the twenty fish embryos were transferred together in 820 µl into a 
test tube using a pipette 5000 and thereafter reaction was initiated by NADPH 
at the latest 2 hpf. The incubation was performed for 60 min in a shaking water 
bath at 32°C, 100 rpm. 
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 For benzo[a]pyrene and thalidomide, the MAS was prepared in a 
polypropylene test tube stored on ice, filled with Tris-HCl buffer (0.1 M), 
microsomes (i.e., premix). NADPH was weighted in a brown glass, dissolved 
with Tris-HCl buffer and stored on ice. 
 
 A 5 min preincubation step was performed at 32°C and 100 rpm for the 
test tubes containing the premix and the NADPH stock solution (10 mM). 
Afterwards, the twenty fish embryos were transferred together in 820 µl into a 
test tube using a pipette 5000 and thereafter DMSO and/or the test material 
were added. Reaction was initiated by NADPH at the latest 2 hpf. The 
incubation was performed for 60 min in a shaking water bath at 32°C, 100 rpm. 
 
3.3.1.4.3 Eggs development 
 
 The exposure was stopped by transferring the fish embryos into 
different Petri dishes filled with fish medium (1 Petri dish/group). The fish 
embryos were then exposed individually in 24-well plates containing 2 ml fish 
medium per well and left for 48 h at 26°C with a 12 h light – 12 h dark cycle in a 
precision incubator. After 48 hpf, the fish embryos were anesthetized and killed 
with a MS-222 solution (0.3%). 
 
3.3.2 Evaluation 
3.3.2.1 Scoring 
 
 At different time points, i.e., 8, 24 and 48 hpf, fish eggs were evaluated 
and scored for lethal or teratogenic effects using an inverted microscope with 
phase contrast optics, a mounted time-lapse recorder and the analySIS 
software. The different lethal or teratogenic endpoints are summarized in Table 
3-2. The effects observed were documented under the Quality Management 
System (QMS) established at the Merck preclinical development division. 
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Table 3-2 Lethal and teratogenic effects observed in zebrafish D. rerio embryos 
depending on the observation time (Bachmann, 2002; Nagel, 2002) 
 
Category Physiological / dysmorphogenic effect
8 
hpf 
24 
hpf 
48 
hpf 
Lethal effect Coagulated egga + + + 
Teratogenic effects Malformation of head  + + 
 Malformation of tailb  + + 
 Malformation of endtailc  + + 
 Malformation of sacculi/otoliths*  + + 
 Malformation of heart*  + + 
 Modification of the spinal chord structure*  + + 
 Scoliosis  + + 
 Rachischisis  + + 
 Deformity of yolk*  + + 
 Growth retardationd  + + 
  Note. 
aThe lethal effect was assessed when there was no more clear organs structure recognition.  
bMalformation of the tail was assessed when the tail was bended or not completely detached from the yolk 
sac 
cMalformation of the endtail was assessed when the spike was bended or twisted 
dGrowth retardation was assessed in comparison to the control eggs. Different parameters were included: 
The global size of the fish egg, the eye and the sacculi/otoliths position, the degree of pigmentation, the tail 
not detached and the frequency of spontaneous movement .  *See Glossary. 
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3.3.2.2 Validity parameters 
 
1) The fertilization rate of the fish embryos must be higher than 50%.  
 
2) The assay is considered to be valid if the viability of the control eggs 
(MAS and negative) exceeds or is equal to 90% after 48 hpf (no 
teratogenic or lethal effects).  
 
3.3.2.3 Fingerprint endpoints 
 
Major malformations were defined teratogenic fingerprints if it was 
concentration-dependent and observed in ≥ 50% of the impaired embryos. 
Following the detection of specific teratogenic fingerprint, the evaluation of in 
vitro test systems was based on the comparison of effectiveness in the test 
system with documented in vivo effects (Piersma, 2004). 
 
3.3.2.4 Statistics 
 
 A one-way analysis of variance (ANOVA) test was run and a Tukey’s 
Post Hoc was performed when significant differences were reported. 
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4 Results 
4.1 Development of the mDarT 
4.1.1 Impact of Parameters on fish embryo development without MAS 
4.1.1.1 Overview of the two systems 
 
 The mDarT protocol was developed taking into consideration normal 
fish egg development and optimal rat liver microsome incubation conditions. 
Every parameter was considered to be acceptable if a minimum of 90% of fish 
eggs developed normally. In Table 4-1 the optimal incubation parameters for 
zebrafish D. rerio embryos and rat liver microsomes are summarized. 
 
Table 4-1 Optimal incubation conditions for each system 
 
 Zebrafish D. rerio 
embryo 
Rat liver  
microsomes 
Temperature 26°C 37°C 
Time 48 h 2 h 
Vessels 24-well plate Test tubes 
Agitation n.d. 100-150 rpm 
Medium Fish Medium Tris or Phosphate-buffer 
pH 8 7.4 
Osmolarity 100 mOsm/kg n.d. 
Cofactors n.d. NADPH or NRS 
Additives n.d. MgCl2, EDTA 
Organic solvent DMSO 1% DMSO 0.2% 
 
Note. The following terms were abbreviated: n.d.: no data; NRS: NADPH Regenerating System; EDTA: 
ethylenediaminetetraacetic acid; DMSO: Dimethyl Sulfoxide; rpm: rotation per minute. 
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4.1.1.2 Temperature 
 
 The optimal temperature for mammal microsomes is 37°C. In contrast, 
fish embryos appear to develop normally if they are kept within an eight degree 
range, between 25°C and 33°C. Incubating them for long periods above or 
below these extremes may produce abnormalities (Kimmel et al., 1995). 
Incubation of microsomes is usually performed from 30 to 60 min and is not 
recommended for more than 120 min at 37°C. 
 
To investigate the influence of temperature on zebrafish D. rerio 
development, 20 fish embryos were incubated at three different temperatures 
(26°C, 32°C and 37°C) for 60 and 90 min respectively. Results are displayed in 
Tab. 4-2 
 
Table 4-2 Influence of temperature and incubation time on zebrafish D. rerio embryonic 
development 
 
Control 
group 
Temperature groups 
32°C 37°C 
96 hpf 
26°C 
120 min 60 min 90 min 60 min 120 min 
Σ Teratogenic eggs - - - - - 
Σ Lethal eggs - 1 1 10 10 
Σ Normal eggs 20 19 19 10 10 
% Normal eggs  100 95 95 50 50 
 
Incubation conditions: 24-well plate, fish medium, 2 hpf. 
Note. The following terms were abbreviated: hpf: hours post fertilization; -: No embryo effects; Σ: Sum.
  
 
 At 37°C, 50% of the fish eggs were coagulated independent of the 
incubation time while at 32°C there was ≤ 10% of impaired embryos at either 60 
min or 90 min. Therefore, temperature had a direct influence on fish embryo 
development, whereby increasing temperature resulted in decreased incidence 
of normal eggs. 
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4.1.1.3 Vessels and agitation 
4.1.1.3.1 Vessels 
 
 Vessels may influence fish embryo development and enzyme activity 
depending upon its material and its form. Using Petri dishes or Erlenmeyer 
flasks with their large surface area may enhance O2 transfer between the air-
medium interface for CYP activity and thereby increasing biotransformation. 
Test tubes are regularly used for microsome studies, glass test tubes being 
generally recommended. However, polypropylene test tubes limit microsomal 
protein and lipophilic xenobiotic adhesion onto the test tubes surface. These 
different vessels were tested by incubating with 20 fish eggs. Results are 
displayed in Tab. 4-3. 
 
Table 4-3 Influence of vessels on zebrafish D. rerio embryonic development 
 
Control 
group 
Vessels groups 
96 hpf 
24-well 
plates 
Petri 
dishes Ø 
20 mm 
Erlenmeyer
100 ml 
PP test 
tubes 
Glass test 
tubes 
Σ Teratogenic eggs - - - - - 
Σ Lethal eggs - 4 1 2 2 
Σ Normal eggs 20 36 59 58 58 
Number of experiments 1 2 3 3 3 
% Normal eggs 100 90 98 97 97 
 
Incubation conditions: 90 min, 2 hpf, 32°C, fish medium. 
Note. The following terms were abbreviated: Ø: Diameter; PP: Polypropylene; hpf: hours post fertilization; 
-: No embryo effects; Σ: Sum. 
 
 Lethality and teratogenicity were ≤ 10% in the control and the vessels 
groups. Therefore, the vessel had little impact on fishes embryonic 
development. 
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4.1.1.3.2 Agitation 
 
 The aqueous Boundary Layer (also called the unstirred water layer) is 
a “stagnant” water layer adjacent to each side of a membrane barrier (e.g., 
microsomes, chorion) (Kansy et al., 2004). Its thickness depends on the bulk-
solution stirring. Rate processes, such as xenobiotic biotransformation and 
metabolite uptake depend on the probability of CYPs active site access and 
ability to cross membranes.  
 
 Microsome agitation is usually performed at 100 or 150 rpm 
(Guengerich, 2001). The shaking impact on fish embryos development has not 
been investigated so far. Therefore, fish eggs were incubated at either 100 or 
150 rpm. Tab. 4-4 summarizes the results. 
 
Table 4-4 Influence of agitation on zebrafish D. rerio embryonic development 
 
Control group Agitation groups 
96 hpf 
Fish medium 100 rpm 150 rpm 
Σ Teratogenic eggs - - 1 
Σ Lethal eggs - 1 1 
Σ Normal eggs 20 19 18 
% Normal eggs 100 95 90 
 
Incubation conditions: 90 min, 2 hpf, 32°C and PP test tubes in fish medium. 
Note. The following terms were abbreviated: rpm: rotation per minute; hpf: hours post fertilization; -: No 
embryo effects; Σ: Sum. 
 
 Out of the control and agitation groups, there was ≤ 10% of fish 
embryos exhibiting teratogenic or lethal effects. Thus, agitation had limited 
impact on fish embryonic development although a trend of decreased normal 
eggs was observed. 
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4.1.1.4 Buffer systems 
4.1.1.4.1 Background 
 
 Solvent and pH value are important to prevent protein aggregation and 
keep microsomal activity stable (Schein, 1990). When studying an enzyme one 
must consider (i) enzyme optimum pH (in our case 7.4), (ii) non-specific buffer 
effects on the enzyme, and (iii) interactions with substrates or metals. Since the 
buffering capacity is maximal at the pKa, buffers should be used close to this 
value.  
  
4.1.1.4.2 Phosphate buffer 
 
 Phosphate buffer (pKa value 7.2) might be an ideal buffer system for 
microsomes (Stoll and Blanchard, 1990). However, dissolution of phosphate 
buffer with fish medium resulted in precipitation and thus fish medium was 
substituted for Ultrapure water. Three concentrations were tested (10, 25 and 
50 mM) with the latter being the preferred for microsome activity (as 
recommended by XenoTech and BD Biosciences). The buffer capacity may be 
identical for the three concentrations tested but by using high buffer 
concentration, the ionic strength of the medium can promote stimulatory effects 
on some CYPs activities (Kelley et al., 2005; Yun et al., 1998). 
  
To investigate the impact on zebrafish D. rerio development, 20 fish 
eggs were incubated at different concentrations of Phosphate buffer. Results 
are summarized in Tab. 4-5. 
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Table 4-5 Influence of Phosphate buffer (pH 7.4) on zebrafish D. rerio embryonic 
development 
 
Control 
group 
Phosphate buffer groups 
96 hpf 
Ultrapure 
Water 
Phosphate  
10 mM 
Phosphate  
20 mM 
Phosphate  
50 mM 
Σ Teratogenic eggs - - 1 - 
Σ Lethal eggs 2 4 5 13 
Σ Normal eggs 18 16 14 7 
% Normal eggs 90 80 70 35 
 
Incubation conditions: 90 min, 32°C, 2 hpf, 100 rpm and PP test tubes. 
Note. The following terms were abbreviated; hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 In all buffer groups, there was > 10% impaired embryos. Moreover, 
lethal effects were concentration dependent. Therefore, phosphate buffer was 
considered not to be appropriate for normal embryonic development of fish. 
 
Osmolarity tolerance for zebrafish embryos is up to 100 mOsm/kg. 
Above this value, fish embryos have been shown to exhibit high lethality (Lange 
et al., 1995). To verify this, the osmolarity was measured for 50 mM Phosphate 
buffer, which was 150 mOsm/kg.  
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4.1.1.4.3 Tris buffer 
 
 Tris has a poor buffer capacity below pH 7.5 and its pKa is temperature 
dependent. However, Tris buffer is nonpolar, dissolves totally in fish medium 
and is regularly used in protocols and guidelines focusing on microsome studies 
(Stoll and Blanchard, 1990). Three different concentrations (25, 50 and 100 
mM) of Tris-buffer were tested. Tris was neutralized with HCl at pH 7.6 and 
25°C to reach pH 7.4 at 32°C (there is a decrease of 0.03 pH units for °C 
increment). 
 
To investigate the impact on zebrafish D. rerio embryonic development, 
20 fish eggs were incubated at different concentrations of Tris buffer. Results 
are summarized in Tab. 4-6. 
 
Table 4-6 Influence of Tris-HCl (pH 7.4) on zebrafish D. rerio embryonic development 
 
Control 
group 
Tris-buffer groups 
96 hpf 
Fish 
medium 
Tris-HCl 
25 mM  
Tris-HCl 
50 mM 
Tris-HCl 
100 mM 
Σ Teratogenic eggs - - - - 
Σ Lethal eggs - - - - 
Σ Normal eggs 20 20 20 20 
% Normal eggs 100 100 100 100 
 
Incubation conditions: 90 min, 32°C, 2 hpf, 100 rpm and PP test tubes.  
Note. The following terms were abbreviated: hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 No lethal or teratogenic effects were observed at any concentration. 
Up to 100 mM, Tris-HCl fulfilled the validation criterion.  
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4.1.1.4.4 Cell culture medium 
 
Primary hepatocytes were considered as an alternative to subcellular 
fractions using an indirect co-culture model. 20 fish eggs were exposed to 
hepatocyte cell culture medium (DMEM/F12) with or without serum. Results are 
displayed in Tab. 4-7. 
 
Table 4-7 Influence of DMEM/F12 with or without serum (pH 7.4) on zebrafish D. rerio 
embryonic development 
 
Control group Cell culture medium groups 
96 hpf  
Fish medium 
DMEM/F12 
with serum 
DMEM/F12 
without serum 
Σ Teratogenic eggs - - - 
Σ Lethal eggs - 20 20 
Σ Normal eggs 20 - - 
% Normal eggs 100 0 0 
 
Incubation conditions: 120 min, 2 hpf, 26°C and 24-well plate. 
Note. The following terms were abbreviated: hpf: hours post fertilization; DMEM: Dulbecco’s modified 
eagle medium ;-: No embryo effects; Σ: Sum. 
 
 For both cell culture medium groups, all fish embryos were coagulated 
at 96 hpf. As for Phosphate buffer, high osmolarity may explain the high 
lethality. The cell culture medium osmolarity without serum was 280 mOsm/kg. 
Diluting cell culture medium (1/10, 1/2) was not considered as it would 
drastically reduce primary hepatocytes vitality and thus limit xenobiotic 
biotransformation potential. 
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4.1.2 Impact of MAS on fish embryo development 
4.1.2.1 Characterization of microsomes from different suppliers 
 
 Two microsome suppliers were selected to investigate their impact on 
zebrafish D. rerio embryonic development. The two suppliers do not use similar 
CYP substrates, meaning specific CYP activities cannot be directly compared. 
Therefore, only CYP concentrations were compared in Table 4-8. 
 
Table 4-8 CYP concentrations of In Vitro Technologies and XenoTech microsomes (taken 
from XenoTech and In Vitro Technologies) 
 
Liver microsome fractions 
Rat inducers 
 
ARO* βNF- PB* INH DEX PB βNF Rabbit**
In Vitro Technologies  
(nmol/mg protein) 
1.03 - 0.75 - 1.39 1.64 1.57 
XenoTech 
(nmol/mg protein) 
- 1.82 1.01 1.52 1.85 1.47 1.79 
CYP families induced All All 2E1 3A4 2B1 1A1/2 none 
 
Note. The following terms were abbreviated: ARO: Aroclor1254; βNF: β-Naphthoflavone; PB: 
Phenobarbital; INH: Isoniazid; DEX: Dexamethasone; hpf: hours post fertilization; -: no data. 
*Microsomes treated with Phenobarbital together with β-Naphthoflavone provide a global rise in CYP 
activities in rat liver microsomes similar to Aroclor1254. 
**non-induced rabbit liver microsomes. 
 
 The CYP concentrations from XenoTech microsomes were higher 
compared to In Vitro Technologies microsomes. 
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4.1.2.2 Incubation time and microsome concentration 
4.1.2.2.1 In Vitro Technologies microsomes 
 
 Increasing incubating periods of microsomes with fish embryos may 
increase test materials biotransformation rate and may cover a critical period of 
fish embryo development (i.e., organogenesis) and thus potentially provoke 
substantial teratogenic effects. 
 
 In Vitro Technologies (IVT) Aroclor1254 induced rat liver microsomes 
cover a broad range of CYP activities, thus allowing a wide xenobiotic 
screening. The influence of incubation time combined with Aroclor1254 
microsomes concentration was evaluated: (i) 60 min with two high microsomes 
concentrations (0.7 and 0.8 mg/ml), (ii) 90 min with two intermediate 
concentrations (0.2 and 0.4 mg/ml) and (iii) 240 min with two low concentrations 
(0.01 and 0.1 mg/ml). Results are displayed in Tab. 4-9. 
 
Table 4-9 Influence of Aroclor1254 induced rat liver microsome concentration and 
incubation time on zebrafish D. rerio embryonic development 
 
Control 
group 
IVT rat liver microsome groups 
240 min 60 min 90 min 240 min 48 hpf 
Fish 
medium 
MAS 
ARO 
0.7 mg/ml 
MAS  
ARO 
0.8 mg/ml 
MAS  
ARO 
0.2 mg/ml 
MAS  
ARO 
0.4 mg/ml 
MAS 
ARO 
0.01 mg/ml 
MAS 
ARO 
 0.1 mg/ml 
Σ Teratogenic eggs - 1 5 1 2 1 - 
Σ Lethal eggs 2 3 2 7 8 8 19 
Σ Normal eggs 18 16 13 12 10 11 1 
% Normal eggs 90 80 65 60 50 55 5 
 
Incubation conditions: 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, NADPH (1 mM), PP test tubes 
and Aroclor1254 induced rat liver microsomes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; Aro: Aroclor1254; hpf: 
hours post fertilization; -: No embryo effects; Σ: Sum; PP: polypropylene. 
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 None of the rat liver microsomes groups were within the defined 
validity parameters (≤ 10% of impaired embryos). Toxicity increased with 
increasing microsome concentration and incubation time. 
4.1.2.2.2 XenoTech microsomes 
 
 Microsomes from XenoTech induced with Phenobarbital together with 
β-Naphthoflavone provide a global increase in CYP activities in rat liver 
microsomes in a similar manner to Aroclor1254. The influence of incubation 
time combined with microsome concentration was evaluated: i) 60 min with 
three high microsomes concentrations (0.35, 0.7 and 0.8 mg/ml) and ii) 90 min 
with two lower concentrations (0.35, and 0.5 mg/ml). Results are displayed in 
Tab. 4-10. 
 
Table 4-10 Influence of β-Naphthoflavone and Phenobarbital induced rat liver microsome 
concentration and incubation time on zebrafish D. rerio embryonic 
development 
 
Control 
group 
XenoTech Rat liver microsome groups 
90 min 60 min 90 min 48 hpf 
Fish 
medium 
MAS  
βNF-PB 
0.35 mg/ml
MAS  
βNF-PB 
0.7 mg/ml 
MAS  
βNF-PB 
0.8 mg/ml 
MAS  
βNF-PB 
0.35 mg/ml 
MAS  
βNF-PB 
0.5 mg/ml 
Σ Teratogenic eggs - - 1 1 - 3 
Σ Lethal eggs - 2 - 2 2 2 
Σ Normal eggs 20 18 19 17 18 15 
% Normal eggs 100 90 95 85 90 65 
 
Incubation conditions: 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, NADPH (1 mM), PP test tubes 
and β-Naphthoflavone-Phenobarbital induced rat liver microsomes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; βNF: β-Naphthoflavone; 
PB: Phenobarbital; hpf: hours post fertilization; -: No embryo effects; Σ: Sum; PP: polypropylene. 
 
 Fish embryos can be incubated either for 60 min with 0.7 mg/ml βNF-
PB induced rat liver microsomes or for 90 min with 0.35 mg/ml induced βNF-PB 
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rat liver microsomes and fulfil the validation criterion (≤ 10% of impaired 
embryos). As it was observed with the In Vitro Technologies microsomes, 
toxicity increased with higher microsome concentrations and incubation times. 
 
4.1.2.3 Different CYP family inducers 
4.1.2.3.1 Aims 
 
Specifically induced rat liver microsomes are of relevance when the CYP 
family is known for the xenobiotic under investigation (see Table 1-2 and Table 
4-8). However, it has been reported that the production of ROS, mediated by 
liver microsomes was influenced by specific CYP families. Thus, in rat liver 
microsomes, CYP2E1 was found to be more active in producing H2O2 (by-
product of CYP cycle) compared with several other CYPs families (Puntarulo 
and Cederbaum, 1998), meaning Isoniazid rat liver microsomes may be more 
toxic than Aroclor1254 rat liver microsomes using the same concentration. To 
verify this theory, microsomes induced by different inducers were investigated. 
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4.1.2.3.2 In Vitro Technologies microsomes  
 
 20 Fish eggs were incubated with three different induced rat liver 
microsomes: a mix of Aroclor1254 and Isoniazid (50:50), Isoniazid alone and β-
Naphthoflavone alone. Each microsome fraction was tested at two different 
concentrations. Results are displayed in Tab. 4-11. 
 
Table 4-11 Influence of different CYP inducers and rat liver microsome concentration on 
zebrafish D. rerio embryonic development 
 
IVT rat liver microsomes groups 
Control 
group 
MAS ARO / INH MAS INH MAS βNF 48 hpf 
Fish 
medium 
0.15 
mg/ml 
0.6 
mg/ml 
0.3 
mg/ml 
0.8 
mg/ml 
0.15 
mg/ml 
0.35 
mg/ml 
Σ Teratogenic eggs - 4 8 4 8 4 - 
Σ Lethal eggs 2 2 4 - 1 14 20 
Σ Normal eggs 18 14 8 16 11 2 - 
% Normal eggs 90 70 40 80 55 10 - 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, NADPH (1 mM) and PP 
test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; ARO: Aroclor1254; βNF: 
β-Naphthoflavone; INH: Isoniazid; hpf: hours post fertilization; PP: polypropylene; -: No embryo effects; Σ: 
Sum. 
 None of the rat liver microsome groups were within the defined 
validation criteria (≤ 10% of impaired embryos). Microsome toxicity was 
concentration and inducer dependent. The β-Naphthoflavone rat liver 
microsomes fraction was the most toxic and the Isoniazid rat liver microsome 
fraction was the least toxic. Surprisingly, the Isoniazid rat liver microsomes 
fraction (high concentration of CYP2E1) was not as toxic as previously reported 
(Puntarulo and Cederbaum, 1998). 
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4.1.2.3.3 XenoTech microsomes 
 
 20 Fish eggs were exposed with three different induced rat liver 
microsomes and one non-induced rabbit liver microsomes. For each fraction, 
one unique concentration (0.7 mg/ml) was tested. Results are displayed in Tab. 
4-12 
 
Table 4-12 Influence of different liver microsome fractions on zebrafish D. rerio 
embryonic development 
 
Control 
group 
XenoTech liver microsome groups 
48 hpf 
MAS βNF-PB 
0.7 mg/ml 
MAS βNF 
0.7 mg/ml 
MAS INH 
0.7 mg/ml 
MAS DEX 
0.7 mg/ml 
MAS Rabbit 
0.7 mg/ml 
Σ Teratogenic eggs - 1 1 - 1 
Σ Lethal eggs 2 - - 1 - 
Σ Normal eggs 18 19 19 19 19 
% Normal eggs 90 95 95 95 95 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, NADPH (1 mM) and PP 
test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; βNF: β-Naphthoflavone; 
PB: Phenobarbital; INH: Isoniazid; DEX: Dexamethasone; hpf: hours post fertilization; -: No embryo 
effects; PP: polypropylene; Σ: Sum. 
 
 The control group and the rat liver microsome groups fulfilled the 
validation criteria (≤ 10% of impaired embryos). Fish embryos can be incubated 
for 60 min at 0.7 mg/ml with any of the different XenoTech rat liver microsome 
fractions or rabbit liver microsome fraction.  
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4.1.2.4 Microsome toxicity 
 
Microsome toxicity is mainly driven by lipid peroxidation. It is the initiating 
reaction in a cascade of events (see Fig. 4-1), starting with the oxidation of 
polyunsaturated fatty acids present in the microsome vesicles by radicals or 
electrons to form lipid hydroperoxides. These break down and yield a variety of 
toxic products, mainly aldehydes such as malondialdehyde (Amunom et al., 
2007; Hodgson and Levi, 1997). 
 
 
 
Figure 4-1 Schematic illustrating lipid peroxidation and destruction of membranes 
(Hodgson and Levi, 1997). 
Legend: R: Radical; R
.
: Free Radical; ROO
.
: reactive oxygen species; RH: Radical 
complexed with one Hydrogen atom. 
Lipid peroxidation initiation is reported to be either enzymatic - via 
NADPH-P450 reductase or CYPs - or non-enzymatic when it is strongly 
affected by transition metals, such as endogenous Fe2+ that can be present in 
the original microsome suspension (Marmunti et al., 2004) (Aviram et al., 1999) 
(Puntarulo and Cederbaum, 1998). However, other parameters may explain 
microsome toxicity. During liver homogenization, phospholipases and proteases 
are released and can be present in microsome preparations if appropriate care 
is not taken.   
 Inhibition of non-enzymatic lipid peroxidation and protease activity may 
limit toxicity and increase the percentage of normal embryos when incubated 
with microsomes.  
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4.1.2.5 Influence of additives 
4.1.2.5.1 Ethylenediaminetetraacetic acid 
 
Lipid peroxidation can be stimulated by inorganic iron compounds, but to 
a greater extent if adenine nucleotides, containing iron compounds as a 
contaminant, are also present (Wills, 1969). Therefore, a chelating agent such 
as ethylenediaminetetraacetic acid (EDTA) was investigated to test for reduced 
microsome toxicity (Hayes, 2001). 
 
EDTA impact was evaluated using two concentrations (0.5 mM and 1 
mM) with 20 fish eggs incubated with the MAS (see Tab. 4-13). 
 
Table 4-13 Influence of EDTA on zebrafish D. rerio embryonic development 
 
Control group EDTA groups 
96 hpf MAS ARO 
0.7 mg/ml 
MAS ARO 
0.7 mg/ml 
0.5 mM EDTA 
MAS ARO 
0.7 mg/ml 
1 mM EDTA  
Σ Teratogenic eggs 1 - 1 
Σ Lethal eggs 2 5 8 
Σ Normal eggs 17 15 11 
% Normal eggs 85 75 55 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, In Vitro Technologies 
liver microsomes, NADPH (1 mM) and PP test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; ARO: Aroclor1254; 
EDTA: ethylenediaminetetraacetic acid; hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 The control group (MAS alone) was below the validation criterion (85% 
instead of ≥ 90% normal embryos). The MAS with 0.5 mM of EDTA triggered 
normal development of 75% eggs and only 55% were normally developed with 
1 mM EDTA in MAS. The addition of EDTA did not reduce the number of 
impaired embryos but, in contrast, increased the final toxicity. 
 
Results 
71 
4.1.2.5.2 Protein inhibitor cocktail 
 
 The presence of proteases or phospholipases may increase 
microsome toxicity. Therefore, induced rat liver microsome fractions were 
incubated with a protein inhibitor cocktail (PIC) specific for mammal proteolytic 
enzymes (i.e., serine, cysteine, aspartic proteases).  
  
 PIC impact was investigated using two concentrations - 1X and 2X 
(see Note). The cocktail was incubated with 20 fish eggs and the MAS. Results 
are displayed in Tab. 4-14. 
 
Table 4-14 Influence of a protein inhibitor cocktail on zebrafish D. rerio embryonic 
development 
 
Control group PIC groups 
96 hpf MAS ARO 
0.7 mg/ml 
MAS ARO 
0.7 mg/ml 
PIC 1X 
MAS ARO 
0.7 mg/ml 
PIC 2X 
Σ Teratogenic eggs 1 - - 
Σ Lethal eggs 2 9 14 
Σ Normal eggs 17 11 6 
% Normal eggs 85 55 35 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, In Vitro Technologies 
liver microsomes, NADPH (1 mM) and PP test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; ARO: Aroclor1254; PIC 
1X: Protein Inhibitor Cocktail (4-(2-Aminoethyl) benzene sulfonyl fluoride hydrochloride – 1 mM; Aprotinin 
– 0.8 µM; Bestatin – 50µM; E-64 Protease Inhibitor – 15 µM; Pepstatin A – 10 µM); PIC 2X: Protein 
Inhibitor Cocktail with double concentration; hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 The control group (MAS alone) was below the validation criterion (85% 
instead of ≥ 90% normal embryos). 55% fish embryos exposed with MAS and 
PIC 1X developed normally and only 35% when fish embryos were exposed to 
PIC 2X. None of the PIC groups limited the toxicity of the MAS. In fact, the fish 
embryo toxicity increased with the addition of PIC. 
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4.1.2.5.3 Dimethyl Sulfoxide 
 
 Dimethyl Sulfoxide (DMSO), a small amphiphilic molecule, is widely 
used as an organic solvent when xenobiotics with low water solubility need to 
be dissolved. It has been estimated that more than 30% of drug discovery 
compounds have an aqueous solubility of less than 10 µM (Di et al., 2006). 
Moreover, DMSO is not only known as a potent organic solvent, it may also 
modify membrane structure by thinning it or creating pores (Gurtovenko and 
Jamshed, 2007). 
 
 DMSO toxicity was previously assessed in zebrafish D. rerio embryos 
and no effect on exposed eggs was recorded with DMSO concentrations up to 
2% (v/v) (Hallare et al., 2006). However, teratogenic effects were not 
investigated and moreover synergistic effects may occur between DMSO and 
Tris buffer. Therefore, fish embryos (20 each) were exposed to different 
concentrations of DMSO in Tris buffer. Results are summarized in Tab. 4-15. 
 
Table 4-15 Influence of DMSO concentration on zebrafish D. rerio embryonic 
development 
 
 
Control group 
 
DMSO groups / Tris-HCl 
 96 hpf 
Fish medium 
DMSO 0.5% 
(v/v) 
DMSO 1% 
(v/v) 
DMSO 2% 
(v/v) 
Σ Teratogenic eggs - - 1 - 
Σ Lethal eggs - - 1 - 
Σ Normal eggs 20 20 18 20 
% Normal eggs 100 100 90 100 
 
Incubation conditions: 60 min, 100 rpm, 32°C, 2 hpf, Tris-HCl (0.1 M) at pH 7.6 and PP test tubes. 
Note. The following terms were abbreviated: DMSO: Dimethyl Sulfoxide; hpf: hours post fertilization; -: No 
embryo effects; Σ: Sum; v/v: volume/volume. 
 
 Up to 2% DMSO (v/v) the normal development of fish eggs was ≥ 
90%. DMSO is also known to inhibit several CYP families and may further be 
Results 
73 
metabolized to a toxic metabolite namely DMSO2 (Chauret et al., 1998) 
(Gerhards and Gibian, 1967; Hickman et al., 1997) (Jia and Liu, 2007). 
 
 20 Fish eggs were incubated with different concentrations of DMSO 
and liver microsome from rat or rabbit. Results are displayed in Tab. 4-16. 
 
Table 4-16 Influence of DMSO concentration on zebrafish D. rerio embryonic 
development with different liver microsomes. 
 
Control 
groups 
MAS-DMSO groups 
MAS 
βNF 
MAS 
Rabbit 
MAS 
INH 
48 hpf 
MAS  
βNF  
MAS  
INH  
MAS  
Rabbit
0.2% 1% 0.2% 1% 0.2% 1% 
Σ Teratogenic eggs 1 - - - 2 - - 2 1 
Σ Lethal eggs - 1 2 - 5 - 4 15 19 
Σ Normal eggs 19 19 18 20 13 20 16 3 - 
% Normal eggs 95 95 90 100 65 100 80 15 0 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, XenoTech liver 
microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; βNF: β-Naphthoflavone; 
PB: Phenobarbital; INH: Isoniazid; DMSO: Dimethyl Sulfoxide; hpf: hours post fertilization; -: No embryo 
effects; Σ: Sum. 
 
 All control groups (MAS alone) fulfilled the validation criteria (≤ 10% of 
impaired embryos). DMSO combined with the MAS was toxic to fish eggs when 
its percentage was 1% (v/v). At 0.2% (v/v) the validation criterion was fulfilled 
for βNF-induced rat liver microsomes and rabbit liver microsomes.   
 
The percentage of normal eggs dropped with Isoniazid-induced liver 
microsomes (no normal eggs with 1% of DMSO). Indeed, this inducer raised 
specifically CYP2E1 that can specifically metabolize DMSO, due to its small 
active site (Jain and Lyer, 2004). The final percentage of DMSO for any kind of 
microsome fractions must be kept ≤ 0.2% (v/v). 
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4.1.2.6 Multiple thawings 
 
 Microsomes are stable indefinitely at or below -70°C and typically 
thawed in a water-bath at 25°C for 5 min, stored on ice and the remainder 
refrozen after use (Pearce et al., 1996). One must consider that the enzyme 
degradation rate in microsomes is proportional to the temperature increase and 
to multiple thawings. 
 
 Therefore it was investigated whether fish egg development was 
influenced when rat liver microsomes were subjected to as many as 3 cycles of 
thawing and refreezing. Results are displayed in Tab. 4-17. 
 
Table 4-17 Influence of multiple thawings on zebrafish D. rerio embryonic development 
 
Control 
groupa 
Thawing-Freezing 
cycle 
48 hpf 
Tris-HCl 
buffer 
1 2 3 
Σ Teratogenic eggs - - - 1 1 - 
Σ Lethal eggs - - - - 2 3 
Σ Normal eggs 40 40 40 39 37 37 
% Normal eggs 100 100 100 98 93 93 
 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, βNF-PB treated 
XenoTech liver microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
Note. a Three independent experiments values are represented in each group 
The following terms were abbreviated: MAS: Metabolic Activation System; βNF: β-Naphthoflavone; PB: 
Phenobarbital; hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 Controls and thawing groups fulfilled the validation criterion (≤ 10% of 
impaired embryos). Multiple thawings of microsomes had no effect on zebrafish 
D. rerio development. However, the more cycle of thawing and freezing were 
performed the more toxic were the microsomes. 
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4.1.2.7 MAS Cofactors 
 
 For practical reasons, NADPH was previously used as a standard 
cofactor source with MAS. However, NRS, composed of NADP+, glucose-6-
phosphate and glucose-6-phosphatase dehydrogenase, is generally used to 
assure maintenance of saturating NADPH concentrations and NADPH-P450 
reductase activity (Guengerich, 2001). Indeed: (i) the NADPH/NADP+ ratio is in 
the favour of NADPH and allow its reaction with the NADPH-P450 reductase, 
(ii) NADP+ inhibits NADPH-P450 reductase competitively and (iii) NRS is half 
the cost of NADPH (Guengerich, personal communication). 
 
 Therefore, 20 fish eggs were incubated with either NADPH (1mM) or 
NRS (1X) - see Note. Results are displayed in Tab. 4-18. 
 
Table 4-18 Influence of MAS cofactors on zebrafish D. rerio embryonic development 
 
Control 
group 
Cofactor group 
48 hpf 
MAS βNF-PB  
NADPH 1 mM  
MAS βNF-PB  
NRS 1X 
Σ Teratogenic eggs - 1 
Σ Lethal eggs 1 3 
Σ Normal eggs 19 16 
% Normal eggs 95 80 
 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, β-Naphthoflavone-
Phenobarbital XenoTech liver microsomes (0.35 mg/ml) and PP test tubes. 
Note. The following terms were abbreviated: MAS: Metabolic Activation System; βNF: β-Naphthoflavone; 
PB: Phenobarbital; NRS 1X: NADPH Regenerating System using supplier stock solution concentration; 
hpf: hours post fertilization; -: No embryo effects; Σ: Sum. 
 
 The control group was within the validation criteria (≤ 10%). When 
NRS 1X was used with MAS there were 3 lethal eggs and 1 teratogenic egg 
resulting in ≥ 10% impaired embryos. Despite the obvious NRS advantages, it is 
not appropriate for cultures with zebrafish D. rerio embryos. 
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4.1.3 Increasing the MAS activity 
4.1.3.1 Reference Proteratogen 
 
 To investigate MAS activity, CPA was chosen as a reference 
proteratogen. It is one of the best studied proteratogens and is listed as an 
excellent candidate compound for use in the validation of in vitro teratogenesis 
assays (Bremer et al., 2002; Flick and Klug, 2006; Fort et al., 1988; Smith et al., 
1983). A range finding study with multiple concentration of CPA alone was 
investigated with 20 fish embryos per group (see Tab. 4-19).  
 
Table 4-19 Influence of CPA on zebrafish D. rerio embryonic development 
 
Internal 
control 
Cyclophosphamide groups 
48 hpf 
Tris-HCl 
0.1 M 
CPA 
3.5 mM 
CPA 
7 mM 
CPA 
14 mM 
CPA 
28 mM 
N Teratogenic eggs - - - - - 
N Lethal eggs - - - - - 
N Normal eggs 20 20 20 20 20 
% Normal eggs  100 100 100 100 100 
 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, and PP test tubes. 
Note: The following terms were abbreviated: CPA: Cyclophosphamide; -: No embryo effects; N: Number. 
 
Up to 28 mM, there was no lethal or teratogenic effect on the zebrafish 
eggs. 
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4.1.3.2 Microsome inducers 
4.1.3.2.1 Overview 
 
CPA metabolism by rat tissues has been extensively investigated. It has 
been found that the rat liver is the principal site of biotransformation. Rat liver 
microsomes when given NADPH and oxygen, will transform CPA to alkylating 
and cytotoxic metabolites (Torkelson et al., 1974). In mammals, CPA is 
oxidatively activated by CYP2C6/2C11 and CYP2B1 (Gut et al., 2000). MAS 
activity was assessed using lethal and teratogenic eggs. 
 
4.1.3.2.2 PB-induced rat liver microsomes 
 
 20 Fish eggs were incubated with CPA and Phenobarbital (PB) 
induced rat liver microsomes that contained, among other CYPs, a high 
concentration of CYP2B1 (see Tab. 1-2 and Tab. 4-8). Results are displayed in 
Tab. 4-20.  
 
Table 4-20 Influence of PB induced rat liver microsomes on zebrafish D. rerio embryonic 
development 
 
Negative 
control 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(PB) 
MAS 
CPA 
1.75 mM
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
N Teratogenic eggs - - - 2 6 4 4 
N Lethal eggs - 2 2 4 6 2 - 
N Normal eggs 20 18 18 14 8 14 16 
% Teratogenic eggsa  - - - 13 43 22 20 
% Lethal eggs - 10 10 20 30 10 - 
 
a Percentage of teratogenic eggs based on surviving eggs 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, Phenobarbital induced 
rat liver XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
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The following terms were abbreviated: MAS: Metabolic Activation System; PB: Phenobarbital; hpf: hours 
post fertilization; -: No embryo effects; N: Number. 
 
 The control groups (CPA alone and MAS alone) displayed ≤ 10% 
impaired embryos. The test groups displayed lethal and teratogenic effects on 
fish embryos although it was not concentration dependent. Indeed, a maximal 
abnormality and lethality was observed of 7 mM CPA with MAS-PB. Rat liver 
microsomes induced with PB are therefore not appropriate for CPA 
biotransformation. Moreover, it was reported that rat liver microsomes induced 
with PB decreased levels of alkylating metabolites of CPA in animals (Ruzicka 
and Ruenitz, 1992).  
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4.1.3.2.3 βNF & PB induced rat liver microsomes 
  
 20 Fish eggs were incubated with CPA and β-Naphthoflavone (βNF) - 
Phenobarbital (PB) induced rat liver microsomes that cover a broad range of 
CYP activities (see Tab. 1-2 and Tab. 4-8). Results are displayed in Tab. 4-21.  
 
Table 4-21 Influence of βNF-PB induced rat liver microsomes on zebrafish D. rerio 
embryonic development 
 
Negative 
controla 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(βNF-PB)
MAS 
CPA 
1.75 mM
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
N Teratogenic eggs - - - - 3 4 1 3 1 5 7 4 6 6 
N Lethal eggs - - - - - - - 1 3 - 2 3 2 1 
N Normal eggs 20 20 20 20 17 16 19 16 16 15 11 13 12 13 
Σ Teratogenic eggs - - 7 4 6 11 12 
Σ Lethal eggs - - - 1 3 5 3 
Σ Normal eggs 40 40 33 35 31 24 25 
% Teratogenicb 0 0 18 (±6) 11 (±13) 16 (±22) 32 (±18) 33 (±1) 
% Lethal eggsc 0 0 0 3 (±4) 8 (±11) 13 (±4) 8 (±4) 
 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, β-Naphthoflavone and 
Phenobarbital rat liver XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
Note.  
a Two independent experiments values are represented in each group 
b Mean percentage ± SD of teratogenic eggs based on surviving eggs (two experiments) 
c Mean percentage ± SD of lethal eggs based on all eggs (two experiments) 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; Σ: Sum; N: Number; SD: Standard Deviation. 
  
 All the control groups fulfilled the validation criteria (≤ 10% impaired 
embryos). In parallel, all the test groups displayed lethal and teratogenic effects 
in fish embryos. The highest concentration (28 mM) triggered up to 33% 
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malformations on zebrafish embryos. However, effects displayed didn’t reach 
100% lethality or teratogenicity. 
 
 βNF-PB induced rat liver microsomes triggered strong teratogenic 
effects on fish embryos in a concentration-dependent manner. However, the 
effects observed didn’t reach 100% lethality or teratogenicity. 
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4.1.3.3 Enzyme stability 
 
 Enzyme activity is dependent on many factors (e.g., medium, pH, 
temperature, 3D-configuration). In addition, protein stability in solution is 
affected by ionic compounds and can affect positively or negatively enzyme 
reactions. Small anions, such as chlorides, are more destabilizing than citrate or 
acetate anions (Schein, 1990). Thus, 20 fish eggs were incubated with CPA and 
MAS using Tris-acetate buffer. Results are displayed in Tab. 4-22. 
 
Table 4-22 Impact of neutralizing agent on CPA biotransformation rate 
 
Negative 
control 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(βNF-PB) MAS CPA 
1.75 mM 
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
N Teratogenic eggs - - - 1 1 - 1 
N Lethal eggs - 2 5 2 2 2 2 
N Normal eggs 20 18 15 17 17 18 17 
% Teratogenic eggsa - - - 6 6 - 6 
% Lethal eggs - 10 25 10 10 10 10 
 
Incubation conditions: 90 min, 100 rpm, 32°C, Tris-Acetate (0.1 M) at pH 7.6, 2 hpf, β-Naphthoflavone 
induced rat liver XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; N: Number. 
 
 All the control groups fulfilled the validation criteria (≤ 10% impaired 
embryos). In all the test groups, except for the first concentration (1.75 mM), 
little effects (lethal and teratogenic) were observed (max. three affected eggs). 
Lethal and teratogenic effects did not display any concentration-response effect. 
HCl substitution by acetate did not increase the number of lethal and 
teratogenic fish embryos. 
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4.1.3.4 Agitation 
 
 Rate processes, such as xenobiotic transformation or metabolite 
uptake, depend on access to the CYP active site and to their ability to cross 
membranes. Therefore, different rates of stirring were tested to evaluate their 
contribution to CPA biotransformation. 20 Fish eggs were incubated with CPA 
and MAS for different shaking speeds, 100, 125 or 150 rpm. Results are 
displayed in Tab. 4-23. 
 
Table 4-23 Influence of agitation on CPA biotransformation rate  
 
Negative 
control 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(βNF-PB) 
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS  
CPA 
14 mM 
MAS 
CPA 
28 mM 
rpm 10
0 
12
5 
15
0 
10
0 
12
5 
15
0 
10
0 
12
5 
15
0 
10
0 
12
5 
15
0 
10
0 
12
5 
15
0 
10
0 
12
5 
15
0 
N Teratogenic eggs - - - - - - 3 2 - 5 4 - 4 8 4 6 4 2 
N Lethal eggs - - - - - - 1 - 2 - 2 2 3 - 6 1 6 10 
N Normal eggs 20 20 20 20 20 20 16 18 18 15 14 18 13 12 10 13 10 8 
% Teratogenic eggsa - - - - - - 16 10 - 25 22 - 24 40 29 32 29 20 
% Lethal eggs - - - - - - 5 - 10 - 10 10 15 - 30 5 30 50 
 
Incubation conditions: 90 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, β-Naphthoflavone rat liver 
XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
Note:a Percentage of teratogenic eggs based on surviving eggs. 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo exhibited effects; rpm: rotation per minute; N: 
Number. 
 
 The controls (CPA and MAS alone) fulfilled the validation criterion i.e., 
no fish eggs displayed any lethal or teratogenic effects.  
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 For each stirring rate, there was a concentration-dependent response 
in defected embryos (coagulated and malformed).  
 
 For low CPA concentrations (3.5 mM and 7 mM), impaired eggs 
decreased with increasing agitation while for high CPA concentrations (14 mM 
and 28 mM) it increased. Therefore high agitation speed could enhance rate 
processes. 
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4.1.3.5  Start of exposure  
 
 The chorion membrane, a thick three-layer membrane encircling 
zebrafish embryo, works as a barrier to the external medium composition. 
Before hardening with time the chorion is still permeable at early stages (≤ 1 
hpf) (Adams et al., 2005; Bonsignorio et al., 1996; Gellert and Heinrichsdorff, 
2001). Therefore, 20 fish eggs were incubated 1 hpf instead of 2 hpf with CPA 
and MAS to enhance metabolite uptake into the eggs. Results are displayed in 
Tab. 4-24. 
 
Table 4-24 Influence of start of exposure on CPA biotransformation rate 
 
Negative 
control 
Test groups 
CPA 
28 mM 
MAS 
control 
(βNF-PB) MAS CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
48 hpf 
1 hpf 2 hpf 1 hpf 2 hpf 1 hpf 2 hpf 1 hpf 2 hpf 1 hpf 2 hpf 1 hpf 2 hpf 
N Teratogenic eggs - - - - 3 3 3 5 2 4 2 6 
N Lethal eggs - - 2 - 3 1 9 - 3 3 8 1 
N Normal eggs 20 20 18 20 14 16 8 15 15 13 10 13 
% Teratogenic eggsa 18 16 27 25 12 24 20 32 
% Lethal eggs 
- 
- 
- 
- 
- 
10 
- 
- 15 5 45 - 15 15 40 5 
 
Incubation conditions: 90 min, 32°C, 100 rpm, 1 hpf, Tris-HCl (0.1 M) at pH 7.6, β-Naphthoflavone and 
Phenobarbital induced rat liver XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and PP test tubes. 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. 
The following terms were abbreviated: hpf: hours post fertilization; CPA: Cyclophosphamide; MAS: 
Metabolic Activation System; PB: Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; N: 
Number.  
 Control groups have ≤ 10% malformed embryos. There were no 
concentration-dependent lethal and teratogenic effects at 1 or 2 hpf. However, 
when test groups were incubated 1 hpf, teratogenic and lethal effects were in 
general stronger than 2 hpf. Therefore, chorion might be more permeable at 
early stages leading to more severe impairments in fish embryos. 
Results 
85 
4.1.3.6  Vessels 
 
 Polypropylene test tubes were used for the mDarT development 
method since they are thought to limit microsomal protein and lipophilic 
xenobiotic adhesion onto the test tubes surface. However, glass test tubes are 
generally used for liver microsomes studies. To verify the impact of the vessel 
on CPA biotransformation, 20 fish eggs were exposed in glass test tubes with 
CPA and MAS. Results are displayed in Tab. 4-25. 
 
Table 4-25 Influence of glass test tubes on CPA biotransformation rate 
 
Negative 
control 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(βNF-PB) MAS CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
N Teratogenic eggs - - 2 - 2 1 
N Lethal eggs - 1 4 4 7 4 
N Normal eggs 20 19 14 16 11 15 
% Teratogenic eggsa - - 13 - 15 6 
% Lethal eggs - 5 20 20 35 20 
 
Incubation conditions: 90 min, 32°C, 100 rpm, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, β-Naphthoflavone rat 
liver XenoTech microsomes (0.35 mg/ml), NADPH (1 mM) and glass test tubes. 
Note:a Percentage of teratogenic eggs based on surviving eggs. 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; N: Number. %: percentage.  
 
 The experiment is considered to be valid as the number of impaired 
embryos is ≤ 10% in control groups. The test groups combined with the MAS 
and CPA showed teratogenic and lethal effects, but it was not concentration-
dependent as the greatest effect was observed with one concentration (14 mM). 
Therefore, glass test tubes did not enhance CPA biotransformation. 
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4.1.4 Standard protocol 
 
 Microsome concentration was previously 0.35 mg/ml as a standard 
value with MAS. Biotransformation of the test material is usually proportional to 
the microsome concentration. To verify this assumption, 20 fish eggs were 
exposed with CPA and a rat liver microsome final concentration of 0.7 mg/ml. 
Results are displayed in Tab. 4-26. 
 
Table 4-26 Influence of microsomes concentration on CPA biotransformation rate 
 
Negative 
Control 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
Control 
(βNF-PB) MAS CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
N Teratogenic eggs - - 1 5 18 5 
N Lethal eggs - 1 - 1 2 15 
N Normal eggs 20 19 19 14 - - 
% Teratogenic eggsa 0 0 5 26 90 100 
% Lethal eggs 0 5 0 5 10 65 
 
Incubation conditions: 60 min, 32°C, 100 rpm, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, β-Naphthoflavone rat 
liver XenoTech microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note:a Percentage of teratogenic eggs based on surviving eggs. 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; N: Number.  
 
 The experiment is considered to be valid as the number of impaired 
embryos is ≤ 10% in the controls. The test groups were concentration-
dependent effects for lethality and teratogenic. Indeed, while the lowest 
concentration (3.5 mM) displayed little teratogenicity (5%), the highest 
concentrations, namely 14 and 28 mM showed respectively 90% and 100% 
teratogenic eggs. 
 
 The mDarT standard protocol (see Tab. 4-27) consists therefore of a 
one hour incubation at 32°C, 100 rpm, with 20 fish embryos 2 hpf, in Tris-HCl 
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(0.1 M) at pH 7.6 exposed to a test material, a final concentration of XenoTech 
rat liver microsomes of 0.7 mg/ml and 1 mM NADPH in polypropylene test 
tubes. 
  
Table 4-27 Standard protocol incubation conditions 
 
 mDarT standard protocol conditions 
Temperature 32°C 
Time of exposure 1 h 
Start of exposure 2 hpf 
Vessels Polypropylene test tubes 
Agitation 100 rpm 
Buffer 0.1 M Tris-HCl dissolved in fish medium 
pH 7.4 
Cofactors 1 mM NADPH  
Microsomes  0.7 mg/ml 
Organic solvent DMSO 0.2 % 
 
4.1.5  Sample preparation for lipophilic conditions 
4.1.5.1 Overview 
 
 B[a]P solubility is dramatically low in standard test conditions. Poorly 
soluble compounds tend to give erratic assay results (Di et al., 2006). While the 
presence of an organic solvent in the aqueous buffer can enhance the solubility 
of compounds, the assay itself can only tolerate a very small amount of organic 
solvent. Indeed, a high amount of organic solvent can inhibit CYP enzyme 
activity and/or affect fish egg development (Chauret et al., 1998). Two sample 
preparation methods were adapted from the aqueous dilution and cosolvent 
method as described by Di et al. in 2006 to enhance B[a]P solubility. These two 
methods may limit precipitation and reduce non-specific binding to plastic-
surfaces. 
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4.1.5.2 Cosolvent method 
 
 B[a]P was prepared following the sample preparation described in 
Annexe A and added to 20 fish eggs. Results are displayed in Table 4-28. 
 
Table 4-28 Influence of the cosolvent method on benzo[a]pyrene biotransformation rate 
 
Negative 
control 
Test groups 
48 hpf B[a]P 
50 µM 
 
MAS 
control 
(βNF)  
MAS 
B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM
N Teratogenic eggs - - - - - - 
N Lethal eggs 20 20 20 20 20 20 
N Normal eggs - - - - - - 
% Teratogenic eggsa  - - - - - - 
% Lethal eggs 100 100 100 100 100 100 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF induced rat liver XenoTech 
microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. Every control and test group had a DMSO and 
ACN final concentration of 0.2% and 1% (v/v), respectively. 
The following terms were abbreviated: B[a]P: Benzo[a]pyrene; MAS: Metabolic Activation System; βNF: β-
Naphthoflavone; -: No embryo effects; DMSO: Dimethyl sulfoxide; ACN: Acetonitrile; N: Number; v/v: 
volume/volume. 
 
 Neither controls nor test groups fulfilled the validation criterion (i.e., 
100% coagulated embryos). Therefore, the cosolvent method was not 
appropriate for mDarT. 
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4.1.5.3 Aqueous dilution method 
  
 B[a]P was prepared following the sample preparation described in 
Annexe A and added to 20 fish eggs. Results are displayed in Table 4-29. 
 
Table 4-29 Influence of the aqueous dilution method on benzo[a]pyrene 
biotransformation rate 
 
Negative 
Control 
Test groups 
48 hpf B[a]P 
50 µM 
 
MAS 
control 
(βNF) 
MAS  
B[a]P 
6 µM 
MAS  
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
N Teratogenic eggs - - - - - - 
N Lethal eggs - - - - - - 
N Normal developed eggs 20 20 20 20 20 20 
% Teratogenic eggsa  - - - - - - 
% Lethal eggs - - - - - - 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF induced rat liver XenoTech 
microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. Every control and test group had a DMSO final 
concentration of 0.2% (v/v). The following terms were abbreviated: B[a]P: Benzo[a]pyrene; MAS: 
Metabolic Activation System; βNF: β-Naphthoflavone; -: No embryo effects; DMSO: Dimethyl Sulfoxide; N: 
Number; v/v: volume/volume.  
 
All controls fulfilled the validation criterion (≤ 10% impaired embryos). 
However, all test groups exhibited no effect on fish embryos. The aqueous 
dilution method addition did not improve B[a]P biotransformation. 
4.1.5.4 Summary of sample preparation 
 
 The cosolvent or aqueous dilution methods did not promote greater 
lethal or teratogenic effects on fish embryos. Therefore, the standard mDarT 
protocol was used further with B[a]P. 
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4.2 Examples of proteratogens tested with mDarT 
4.2.1 Cyclophosphamide 
4.2.1.1 Controls 
 As summarized in Table 4-30, the negative control (CPA without MAS) 
triggered no lethal effects in the fish embryos and only 1 of 60 fish eggs 
displayed malformations (head) within 3 experiments (2% of surviving eggs) 
(see Table 4-31). In the 3 MAS control experiments (MAS alone), 3 fish 
embryos were coagulated (5% of all eggs) and 1 fish embryo displayed 
malformations of the sacculi/otoliths and the end tail (2% of surviving eggs) 
(Table 4-32). The total percentage of teratogenic and/or lethal eggs in each 
individual control group experiment consisting of 20 eggs each (negative or 
MAS control) was ≤ 10% 48 hpf and, thus, all experiments were considered to 
be valid. 
 
Table 4-30 Lethal effects of cyclophosphamide with mDarT 
 
Effects Time 
Negative 
controla 
(CPA)  
MAS 
control 
(βNF-PB)  
MAS 
CPA 
3.5 mM  
MAS 
CPA 
7 mM  
MAS 
CPA 
14 mM  
MAS 
CPA 
28 mM  
- - - - 1 - - - - - - - - - - - - - 
- - - - 2 - - - - 1 3 1 1 2 1 6 5 7 
Coagulated 
eggs 
8 hpf 
24 hpf 
48 hpf - - - 1 2 - - - - 1 3 1 2 2 1 15 18 8 
                    
Note. 
a Three independent experiments values are represented in each group 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; hpf: 
hours post fertilization; - : No lethality observed; PB: Phenobarbital; βNF: β-Naphthoflavone. 
 
4.2.1.2 Lethal and/or teratogenic effects of metabolic activated 
cyclophosphamide in zebrafish D. rerio embryos  
 
 The lethal and/or teratogenic effects observed 48 hpf, which were 
induced in fish embryos incubated with both CPA and rat liver microsomes, are 
summarized in Tables 4-30, 4-31 and 4-32.  
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 Table 4-30 summarizes the lethal effects observed in fish eggs 
incubated with different concentrations of metabolized CPA. There were no or 5 
coagulated eggs of 60 fish eggs at 3.5, 7.0 and 14.0 mM CPA, respectively. 
However, in all 3 single experiments a significant increase of coagulated fish 
eggs was observed 48 hpf at the highest concentration 28 mM (41 of 60 fish 
eggs). In this group a strong increase in the incidence of coagulated eggs was 
observed between 24 and 48 hpf, respectively. 
 
Table 4-31 Overview of lethal and teratogenic effects of cyclophosphamide with mDarT 
 
Negative 
controla 
Test groups 
48 hpf 
CPA 
28 mM 
MAS 
control 
(βNF-PB) 
MAS 
CPA  
3.5 mM 
MAS 
CPA  
7 mM 
MAS 
CPA 
14 mM  
MAS 
CPA  
28 mM 
 N Teratogenic eggs - - 1 - - 1 1 1 2 5 3 2 18 10 6 5 2 12 
 N Lethal eggs - - - 1 2 - - - - 1 3 1 2 2 1 15 18 8 
 N Normal eggs 20 20 19 19 18 19 19 19 18 14 14 17 - 8 13 - - - 
 Σ Teratogenic eggs 1 1 4 10 34 19 
 Σ Lethal eggs - 3 - 5 5 41 
 Σ Normal eggs 59 56 56 45 21 - 
 % Teratogenic 
eggsb  
2 (±3) 2 (±3) 7 (±3) 18 (±8) 62 (±34) ** 100 (±0) ** 
 % Lethal eggsc - 5 (±5) - 8 (±6) 8 (±3) 68 (±26) ** 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF & PB induced rat liver 
microsomes from XenoTech (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note.  
a Three independent experiments values are represented in each group 
b Mean percentage ± SD of teratogenic eggs based on surviving eggs (3 experiments) 
c Mean percentage ± SD of lethal eggs based on all eggs (3 experiments) 
**At p < 0.01, there was a significant difference with the other groups 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; Σ: Sum; N: Number.  
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 In the test groups containing both MAS and CPA, the percentage of 
teratogenic eggs (teratogenic eggs/surviving eggs) clearly increased with 
increasing CPA concentration from 7% (3.5 mM CPA) to 100% (28 mM CPA) 
reaching significance at the two highest CPA concentrations 14 and 28 mM (p < 
0.01) as summarized in Table 4-31. The absolute number of fish eggs 
displaying teratogenic effects increased from 4 (3.5 mM CPA) to 34 (14 mM 
CPA). At the highest concentration (28 mM CPA) the lethal effects were 
predominant i.e., 41 from 60 fish eggs were coagulated. Thus, the absolute 
number of teratogenic fish eggs in the highest concentration group dropped, 
however, all 19 surviving fish embryos of this group displayed malformations 
(100% teratogenic eggs). 
 
 The absolute and relative incidences of the different CPA-induced 
teratogenic endpoints in zebrafish are summarized in Table 4-32 for the 
different control and test groups. With the exception of rachischisis all possible 
malformations listed in Table 3-2 were observed in fish embryos treated with 
metabolized CPA. However, some malformations, such as effects on the head 
occurred more frequently than others. Teratogenic effects were considered as 
“fingerprint-endpoints” if the following criteria were fulfilled: (i) concentration-
response relationship and (ii) the endpoint must be observed in ≥ 50% of all 
teratogenic fish eggs in the test groups. As 67 fish eggs exposed to CPA 
displayed one or more teratogenic effects, a fingerprint-endpoint must be 
observed in at least 33 fish eggs within the three experiments (Tab. 4-32). 
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Table 4-32 Overview of teratogenic effects of cyclophosphamide metabolite(s) in zebrafish D. rerio embryos 
Control groups Test groups 
Malformations Time Negative 
control 
(CPA) 
MAS control 
(βNF-PB) 
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
Σt 
Head 
24 hpf 
48 hpf 
- 
1/60 (2%)a 
2/58 
- 
3/60 
2/60 (3%) 
8/55 
6/55 (11%) 
31/56 
24/55 (44)% 
42/42 
19/19 (100%) 
 
51/67b (76%)c 
Tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
1/55 
- 
6/56 
9/55 (16%) 
10/42 
4/19 (21%) 
 
13/67 
End tail 
24 hpf 
48 hpf 
- 
- 
- 
1/57 (2%) 
- 
2/60 (3%) 
1/55 
3/55 (5%) 
- 
17/55 (31%) 
10/42 
8/19 (42%) 
 
31/67 
Sacculi/Otoliths 
24 hpf 
48 hpf 
- 
- 
- 
1/57 (2%) 
2/60 
2/60 (3%) 
5/55 
7/55 (13%) 
23/56 
20/55 (36%) 
42/42 
17/19 (89%) 
 
46/67 (69%) 
Heart 48 hpf - - 1/60 (2%) 4/55 (7%) 14/55 (25%) 11/19 (58%) 30/67 
Spinal cord structure 
24 hpf 
48 hpf 
- 
- 
- 
- 
1/60 
1/60 (2%) 
6/55 
5/55 (9%) 
4/56 
19/55 (35%) 
37/42 
13/19 (68%) 
 
38/67 (57%) 
Scoliosis 
24 hpf 
48 hpf 
- 
- 
1/58 
- 
- 
- 
1/55 
2/55 (4%) 
6/56 
15/55 (27%) 
4/42 
7/19 (37%) 
 
24/67 
Rachischisis 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
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Table 4-32 to be continued 
Malformations Time 
Negative 
control 
(CPA) 
MAS control 
(βNF-PB) 
MAS 
CPA 
3.5 mM 
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
Σt 
Deformity of yolk 
24 hpf 
48 hpf 
- 
- 
1/58 
- 
1/60 
- 
1/55 
3/55 (5%) 
2/56 
8/55 (15%) 
7/42 
9/19 (47%) 
 
20/67 
Growth retardation 
24 hpf 
48 hpf 
- 
- 
1/58 
- 
1/60 
1/60 (2%) 
7/55 
7/55 (13%) 
4/56 
2/55 (4%) 
39/42 
10/19 (53%) 
 
20/67 
Sum of teratogenic eggsd 1/60 1/57 4/60 10/55 34/55 19/19  
 
Note. 
One teratogenic egg can display multiple malformations 
a Number of eggs displaying this endpoint/number of surviving eggs (%) 
b Number of eggs displaying this endpoint / total number of teratogenic eggs in the test groups.  
c Major fingerprints (> 50%) are represented in bold 
d Sum of the teratogenic eggs per group / number of surviving eggs after 48 hpf 
The following terms were abbreviated: CPA: Cyclophosphamide; MAS: Metabolic Activation System; hpf: hours post fertilization; PB: Phenobarbital; βNF: β-
Naphthoflavone; -: No embryo effects; Σt: Sum of the teratogenic eggs per endpoint out of all teratogenic eggs in the 4 test groups after 48 hpf. 
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 Following these criteria, malformations of the head (51/67) (Fig. 4-2 A, 
B and D), the sacculi/otoliths (46/67) (Fig. 4-2 A, B, C and D), and the spinal 
cord structure (38/67) (Fig. 4-2 C and D), are defined as fingerprint 
malformations of CPA in fish embryos (Fig. 4-2). Other malformations such as 
effects on the end tail (Fig. 4-2 C) or scoliosis (Fig. 4-2 B and C) were also 
observed, however, they didn’t fulfill the criteria for fingerprint endpoints. 
 
  
 
  
 
Figure 4-2 Inverted microscope image of fish embryos exposed to cyclophosphamide 
and microsomes  
A. 24 hpf, 3.5 mM CPA. B. 24 hpf, 7 mM CPA. C., 48 hpf, 14 mM CPA. D. 48 hpf, 
28 mM CPA. Abbreviations: E: Eye; ET: End Tail; H: Head; hpf: hours post 
fertilization; PO: Pericardial Oedema; S: Scoliosis; SC: Spinal Cord; S/O: 
Sacculi/Otoliths; YSO: Yolk Sac Oedema; *: See Glossary. 
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 Figure 4-3 illustrates CPA-induced teratogenic effects depending on 
the concentration of CPA and on the anatomic region within the fish embryo. 
Figures 4-3 A, 4-3 B and 4-3 C display frontal, axial and ventral malformations, 
respectively. Figure 4-3 D presents growth retardation, i.e., the developmental 
stages of the test groups were compared with the control groups. 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3 Summary of individual morphologic malformations in zebrafish D. rerio embryos 
exposed to cyclophosphamide and microsomes 48 hpf.  
Effects on the frontal zone (A), on the axial zone (B) and on the ventral zone (C) are 
differentiated. (D) CPA-induced growth retardation. The standard deviation for each 
parameter is the result of 3 independent experiments.  
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 A clear concentration-response was obtained for all malformations 
observed at the frontal (Fig. 4-3A), axial (Fig. 4-3B) and ventral (Fig. 4-3C) 
zones (see also Table 4-32), i.e., the incidence of malformations increased with 
increasing concentrations of CPA. In contrast, a clear incidence of growth 
retardation (Fig. 4-3D) was only observed in the test group with the highest CPA 
concentration.  
  
 Taken together, a clear concentration-response was observed for both 
lethal and teratogenic effects in D. rerio fish eggs exposed to CPA and a 
mammalian metabolic activation system. Significant increases (p < 0.01) in 
teratogenic effects compared to the controls were observed in test groups 
exposed to 14 and 28 mM CPA. Moreover, a significant increase (p < 0.01) in 
lethality was observed in the highest concentration group (28 mM CPA). Three 
fingerprint malformations (effects on the head, sacculi/otoliths and spinal cord 
structure) were identified in the fish embryos. 
 
 Based on these three studies, a clear concentration-response 
relationship was observed with CPA and MAS, regarding both teratogenic and 
lethal effects. 
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4.2.2 Ethanol 
4.2.2.1 Concentration range finding  
 
 A concentration range finding with multiple concentrations of ethanol 
was investigated with 20 fish embryos per group (see Tab. 4-33).  
 
Table 4-33 Influence of ethanol on zebrafish D. rerio development 
 
Internal 
control 
Ethanol groups 
48 hpf 
Tris-HCl 
0.1 M 
EtOH 
42.5 mM
EtOH 
85 mM 
EtOH 
170 mM 
EtOH 
340 mM 
N Teratogenic eggs - - - - 2 
N Lethal eggs - 2 - 1 16 
N Normal eggs 20 18 20 19 2 
% Normal eggs  100 90 100 95 10 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, and PP test tubes. 
Note: 
The following terms were abbreviated: EtOH: Ethanol; -: No embryo effects; N: Number. 
 
 The internal control fulfilled the validation criterion (≤ 10% impaired 
embryos). At 340 mM, ethanol was highly lethal (80% coagulated eggs). 
Therefore, a final ethanol concentration of up to 170 mM will be combined with 
MAS and fish eggs. 
 
 Microsomes are able to oxidize ethanol via CYPs isoforms 2E1, 1A2 
and 3A4 (Das and Vasudevan, 2007). However, CYP2E1 has the highest 
specificity to oxidize ethanol (Guengerich, 2003),(Jain and Lyer, 2004). 
Isoniazid induced rat liver microsomes have the highest content of CYP2E1. 
Therefore, these microsomes will be combined with ethanol. 
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4.2.2.2 Controls 
 
 As shown in Tables 4-34 and 4-35, only 1 coagulated fish egg (2% of 
all fish eggs) and 4 fish eggs displaying teratogenic effects (7% of surviving 
embryos) were obtained in 3 negative control experiments each consisting of 20 
fish embryos exposed to 170 mM ethanol without MAS. In the 3 MAS control 
experiments (MAS alone), no teratogenic effects were observed, but 4 of 60 fish 
eggs were coagulated (7% of all fish eggs). However, for each control group 
and for the 3 experiments, the acceptance criterion of ≤ 10% impaired embryos 
after 48 hpf was satisfied and, thus, the experiments were considered to be 
valid. 
 
Table 4-34 Lethal effects of ethanol with mDarT 
 
Effects Time 
Negative 
controla 
(EtOH) 
MAS 
control 
(INH) 
MAS 
EtOH 
42.5 mM 
MAS 
EtOH 
85 mM 
MAS 
EtOH 
170 mM 
1 - - 1 - - 1 - - - - - - - - 
1 - - 1 1 2 1 2 1 - 1 1 - 10 2 
Coagulated 
Eggs 
8 hpf 
24 hpf 
48 hpf 1 - - 1 1 2 2 2 1 - 1 2 9 11 2 
                 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, Isoniazid induced rat liver 
microsomes from XenoTech (0.7 mg/ml), NADPH (1 mM), 2 hpf, and PP test tubes. 
Note. 
a Three independent experiments values are represented in each group 
The following terms were abbreviated: EtOH: Ethanol; MAS: Metabolic Activation System; hpf: hours post 
fertilization; INH: Isoniazid; - : No lethality observed. 
 
4.2.2.3 Lethal and/or teratogenic effects of metabolic activated ethanol in 
zebrafish D. rerio embryos 
 
 Lethal and/or teratogenic effects observed 48 hpf in fish embryos 
incubated with both ethanol and rat liver microsomes, are summarized in Tables 
4-34, 4-35 and 4-36. 
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 Table 4-34 summarizes the lethal effects observed in fish eggs 
incubated with different concentrations of metabolized ethanol. Only 5 and 3 
coagulated eggs out of 60 eggs were observed in the test groups exposed to 
42.5 and 85 mM ethanol, respectively. However, a significant increase in 
coagulated fish embryos (22 of 60 fish eggs) was observed after 48 hpf at the 
highest concentration of 170 mM ethanol.  
 
Table 4-35 Overview of lethal and teratogenic effects of ethanol with mDarT 
 
Negative 
controla 
Test groups 
48 hpf 
EtOH 
170 mM 
MAS 
control 
(INH) 
MAS 
EtOH 
42.5 mM 
MAS 
EtOH 
85 mM 
MAS 
EtOH 
170 mM 
N Teratogenic eggs - 2 2 - - - 2 2 2 5 2 7 5 4 8 
N Lethal eggs 1 - - 1 1 2 2 2 1 - 1 2 9 11 2 
N Normal eggs 19 18 18 19 19 18 16 16 17 15 17 11 6 5 10 
Σ Teratogenic eggs 4 - 6 14 17 
Σ Lethal eggs 1 4 5 3 22 
Σ Normal eggs 55 56 49 43 21 
% Teratogenic eggsb 7 (±6) - 11 (±0) 25 (±14)* 45 (±1)* 
% Lethal eggsc 2 (±3) 7 (±3) 8 (±3) 5 (±5) 37 (±24)* 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, Isoniazid induced rat liver 
microsomes from XenoTech (0.7 mg/ml), NADPH (1 mM), 2 hpf, and PP test tubes. 
Note.  
a Three independent experiments values are represented in each group 
b Mean percentage ± SD of teratogenic eggs based on surviving eggs (3 experiments) 
c Mean percentage ± SD of lethal eggs based on all eggs (3 experiments) 
*At p < 0.05, there was a significant difference with the other groups 
The following terms were abbreviated: EtOH: Ethanol; MAS: Metabolic Activation System; INH: Isoniazid; 
-: No embryo effects; Σ: Sum; N: Number. 
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 In the test groups, the incidence of eggs displaying malformations 
(teratogenic eggs/surviving eggs) increased with increasing ethanol 
concentrations from 11% (42.5 mM ethanol) to 45% (170 mM) reaching 
significance at the two highest ethanol concentrations 85 and 170 mM (p < 
0.05) as summarized in Table 4-35. The absolute number of fish eggs 
displaying teratogenic effects were 6, 14 and 17 at 42.5, 85, and 170 mM 
ethanol, respectively, i.e., the absolute number of teratogenic eggs was 
comparable for the two highest ethanol concentrations. However, the incidence 
of teratogenicity (teratogenic eggs/surviving eggs) increased with increasing 
ethanol concentrations, as the lethality was much higher at 170 mM ethanol (22 
coagulated eggs) compared to 85 mM ethanol (3 coagulated eggs).  
  
 The absolute and relative incidences of the different ethanol-induced 
teratogenic endpoints in zebrafish are summarized in Table 4-36. With the 
exception of rachischisis all possible malformations listed in Table 3-2 have 
been observed in fish embryos treated with metabolized ethanol. However, 
some malformations, such as effects on the sacculi/otoliths, occurred more 
frequently than others. According to the criteria mentioned in section 4.2.1.2, as 
37 fish eggs exposed to ethanol displayed one or more teratogenic effects, a 
fingerprint-endpoint must be observed in at least 18 fish eggs within the 3 
experiments. 
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Table 4-36 Overview of teratogenic effects of ethanol metabolite(s) in the zebrafish D. rerio 
Control groups Test groups 
Malformations Time Negative 
control 
(EtOH) 
MAS control 
(INH) 
MAS 
EtOH 
42.5 mM 
MAS 
EtOH 
85 mM 
MAS 
EtOH 
170 mM 
Σt 
Head 
24 hpf 
48 hpf 
1/59 
- 
- 
- 
4/56  
3/55 (5%)a 
9/58 
7/57 (12%) 
9/48  
9/38 (24%) 
 
19/37b (51%)c 
Tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
1/58  
3/57 (5%) 
6/48  
6/38 (16%) 
 
9/37 
End tail 
24 hpf 
48 hpf 
- 
1/58 (2%) 
- 
- 
2/56 
3/55 (5%) 
- 
2/57 (4%) 
3/48 
7/38 (18%) 
 
12/37 
Sacculi/Otoliths 
24 hpf 
48 hpf 
- 
2/58 (3%) 
- 
- 
4/56  
6/55 (11%) 
7/58  
13/57 (23%) 
8/48  
10/38 (26%) 
 
29/37 (78%) 
Heart 48 hpf - - 4/55 (7%) 5/57 (9%) 5/38 (13%) 14/37 
Scoliosis 
24 hpf 
48 hpf 
1/59 
1/58 (2%) 
- 
- 
6/56 
3/55 (5%) 
5/58  
8/57 (14%) 
9/48  
8/38 (21%) 
 
19/37 (51%) 
Spinal Cord Structure 
24 hpf 
48 hpf 
- 
- 
- 
- 
2/56 
4/55 (7%) 
4/58 
10/57 (18%) 
11/48 
12/38 (32%) 
 
26/37 (70%) 
Rachischisis 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
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                Table 4-36 to be continued 
Malformations Time 
Negative 
control 
(EtOH) 
MAS control 
(INH) 
MAS 
EtOH 
42.5 mM 
MAS 
EtOH 
85 mM 
MAS 
EtOH 
170 mM 
Σt 
Deformity of Yolk 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
3/55 (5%) 
4/58  
4/57 (7%) 
3/48  
6/38 (16%) 
 
13/37 
Growth Retardation 
24 hpf 
48 hpf 
- 
- 
- 
- 
2/56  
4/55 (7%) 
5/58 
4/57 (7%) 
7/48 
6/38 (16%) 
 
14/37 
Sum of teratogenic eggsd 4/58 -/55 6/55 14/57 17/38  
 
Note. 
One teratogenic egg can display multiple malformations 
a Number of eggs displaying this endpoint/number of surviving eggs (%) 
b Number of eggs displaying this endpoint / total number of teratogenic eggs in the test groups. 
c Major fingerprints malformations (> 50%) are represented in bold 
d Sum of the teratogenic eggs per group / number of surviving eggs after 48 hpf 
The following terms were abbreviated: EtOH: Ethanol; INH: Isoniazid; MAS: Metabolic Activation System; hpf: hours post fertilization; -: No embryo effects; Σt: Sum of 
the teratogenic eggs per endpoint out of all teratogenic eggs in the 3 test groups after 48 hpf. 
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According to the above-mentioned definition of fingerprint malformations, the 
major endpoints were the effects on the sacculi/otoliths (29/37) (Fig. 4-4 A, B 
and C), the spinal cord structure (26/37) (Fig. 4-4 A, B and C), and the head 
(19/37) (Fig. 4-4 A and C) as well as scoliosis (19/37) (Fig. 4-4 B and C) (≥ 50% 
of all teratogenic fish eggs in the test groups). 
 
   
 
 
 
Figure 4-4 Inverted microscope image of fish embryos exposed to ethanol and 
microsomes. 
A. 42.5 mM EtOH, 24 hpf. B. 85 mM EtOH, 48 hpf C. 170 mM EtOH, 48 hpf. The 
following terms are abbreviated: SC: Spinal Cord; H: Head; Ht: Heart; PO: 
Pericardial Oedema; S/O: Sacculi/Otoliths; YS: Yolk sac; YSO: Yolk Sac Oedema. 
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In Figure 4-5, the teratogenic effects of ethanol are presented depending on the 
anatomic region within the fish embryo. Figures 4-5 A, 4-5 B and 4-5 C display 
frontal, axial and ventral malformations, respectively. Figure 4-5 D summarizes 
growth retardation. 
 
 A clear concentration-response was obtained for all teratogenic effects 
at the frontal (Fig. 4-5 A) and ventral (Fig. 4-5 C) zones. In addition, a 
concentration-dependent retardation of fish embryo development was observed 
in 4 (42.5 mM and 85 mM) and 6 fish eggs (170 mM) (Fig. 4-5 D). The 
incidence of most malformations of the axial region increased with increasing 
concentrations of ethanol. However, incidences of end tail defects (Fig. 4-5 B) 
were not concentration dependent and again no rachischisis was observed 
(Fig.4-5 B). 
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Figure 4-5 Summary of individual morphologic malformations in zebrafish D. rerio embryos 
exposed to ethanol and microsomes 48 hpf.  
 Effects on the frontal zone (A), on the axial zone (B) and on the ventral zone (C). (D). Ethanol-
 induced growth retardation. The standard deviation for each parameter is the result of 3 
 independent experiments.  
 
 Based on these 3 studies, a clear increase of teratogenic incidences 
was observed with increasing concentrations of metabolic activated ethanol, 
reaching significance (p < 0.05) at 85 and 170 mM ethanol, respectively. In 
addition, lethality was significantly increased (p < 0.05) at the highest test 
material concentration (170 mM ethanol). Moreover, four characteristic 
malformations (effects on the sacculi/otoliths, cordal structure and head as well 
as scoliosis) were identified in fish embryos exposed to metabolically activated 
ethanol. 
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4.2.3 Benzo[a]pyrene 
4.2.3.1 Concentration range finding 
 
 A concentration range finding study with multiple concentrations of 
B[a]P alone was investigated with 20 fish embryos per group (see Tab. 4-37). 
 
Table 4-37 Influence of benzo[a]pyrene on zebrafish D. rerio development 
 
Internal 
control 
Benzo[a]pyrene groups 
48 hpf Tris-HCl 
0.1 M 
0.2% DMSO
(v/v) 
B[a]P 
6 µM 
B[a]P 
12 µM 
B[a]P 
25 µM 
B[a]P 
50 µM 
N Teratogenic eggs - - - - - 
N Lethal eggs - 2 - 1 1 
N Normal eggs 20 18 20 19 19 
% Normal  eggs  100 90 100 95 95 
 
Incubation conditions: 60 min, 100 rpm, 32°C, Tris-HCl (0.1 M) at pH 7.6, 2 hpf, and PP test tubes. 
Note: 
The following terms were abbreviated: B[a]P: Benzo[a]pyrene; DMSO: Dimethyl Sulfoxide; -: No embryo 
effects; N: Number; v/v: volume/volume. 
 
The internal control and all the B[a]P groups fulfilled the validation 
criterion (≤10% impaired embryos). Therefore B[a]P concentration was 
combined with mDarT up to 50 µM. 
Results 
108 
4.2.3.2 Selection of microsomes 
4.2.3.2.1 βNF & PB induced rat liver microsomes 
 
 20 Fish eggs were incubated with different concentrations of B[a]P and 
β-Naphthoflavone & Phenobarbital induced rat liver microsomes that cover a 
broad range of CYP activities (see Tab. 1-2). Results are displayed in Tab. 4-
38. 
 
Table 4-38 Influence of βNF-PB induced rat liver microsomes and benzo[a]pyrene on 
zebrafish D. rerio development 
 
Negative 
control 
Positive 
control 
Test groups 
48 hpf 
B[a]P 
50 µM 
MAS 
control 
(βNF-PB) MAS 
CPA 28 mM 
MAS 
B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
N Teratogenic eggs 1 - 7 - 2 - - 
N Lethal eggs - 2 13 4 1 1 1 
N Normal eggs 19 18 - 16 17 19 19 
% Teratogenic eggsa 5 - 100 - 11 - - 
% Lethal eggs - 10 65 20 5 5 5 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF-PB induced rat liver 
XenoTech microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. 
Every control and test group had a DMSO final concentration of 0.2% (v/v). The following terms were 
abbreviated: B[a]P: Benzo[a]pyrene; CPA: Cyclophosphamide; MAS: Metabolic Activation System; PB: 
Phenobarbital; βNF: β-Naphthoflavone; -: No embryo effects; N: Number; v/v: volume/volume. 
 
 The negative and the MAS control groups fulfilled the validation 
criterion (≤ 10% impaired embryos) and the positive control showed that MAS 
was active (100% teratogenic eggs). 
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 When B[a]P was incubated with MAS some defects on fish embryos 
were observed. Low concentrations caused 4 coagulated eggs (20%) at 6 µM 
and 2 teratogenic eggs (11%) and 1 lethal egg (5%) at 12 µM. However, for 
both high concentrations (25 µM and 50 µM), no differences from the negative 
and MAS control groups were observed. 
 
 There was no concentration dependent response between B[a]P-
concentration and no significant difference was observed between the test 
groups and the controls. In conclusion, the βNF-PB induced rat liver 
microsomes were not appropriate for B[a]P biotransformation.  
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4.2.3.2.2 βNF induced rat liver microsomes 
 
 B[a]P can undergo monooxygenation catalyzed by the microsomal 
CYP isoforms 1A1 and 1B1, to yield a series of arene oxides, which can be 
hydrated by mEHs to yield the corresponding toxic metabolites B[a]P-7,8-
dihydrodiol-9,10-epoxide (Jain and Lyer, 2004) (see Fig. 1-26). 
 
 20 Fish eggs were incubated with B[a]P and β-Naphthoflavone 
induced rat liver microsomes that contain high concentrations of CYP1A 
amongst others (see Tab. 1-2). Results are displayed in Tab. 4-39.  
 
Table 4-39 Influence of βNF induced rat liver microsomes and benzo[a]pyrene on 
zebrafish D. rerio development 
 
Negative 
control 
Test groups 
48 hpf 
B[a]P 
50 µM 
MAS 
control 
(βNF) MAS B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
N Teratogenic eggs - - 1 2 3 - 
N Lethal eggs - 2 3 4 4 - 
N Normal eggs 20 18 16 14 13 20 
% Teratogenic eggsa - - 6 13 19 - 
% Lethal eggs - 10 15 20 20 - 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF induced rat liver XenoTech 
microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note: 
a Percentage of teratogenic eggs based on surviving eggs. 
Every control and test group had a DMSO final concentration of 0.2% (v/v). The following terms were 
abbreviated: B[a]P: Benzo[a]pyrene; MAS: Metabolic Activation System; βNF: β-Naphthoflavone; -: No 
embryo effects; N: Number; v/v: volume/volume.  
 
 Negative and MAS control groups fulfilled the validation criterion of ≤ 
10% impaired embryos. In the test groups, defects (teratogenic and lethal) were 
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detected for the first three concentrations (6, 12 and 25 µM). However, at 50 
µM, no effect was observed.  
 B[a]P’s high lipophilicity (LogK(O/W) = 6) may limit its solubilisation in 
Tris-HCl buffer and decrease the biotransformation potential with microsomes at 
B[a]P concentration above 25 µM. To overcome B[a]P insolubility, new sample 
preparation methods were investigated as described in the section 4.1.5.  
 
4.2.3.3 Controls 
 
 As shown in Tables 4-40 and 4-41, there was 1 coagulated fish 
embryo (2% of all fish eggs) in 3 negative control experiments each consisting 
of 20 fish embryos exposed to 50 µM B[a]P without MAS. In the 3 MAS control 
experiments (MAS alone) there was 1 teratogenic fish egg. For each control 
group and for the 3 experiments, the acceptance criterion of ≤ 10% impaired 
embryos 48 hpf was satisfied and thus the experiment were considered to be 
valid. 
 
4.2.3.4 Lethal and/or teratogenic effects of metabolic activated 
benzo[a]pyrene in zebrafish D. rerio embryos 
 
 Lethal and/or teratogenic effects observed 48 hpf in fish embryos 
incubated with both B[a]P and induced rat liver microsomes are summarized in 
Tables 4-40, 4-41 and 4-42.  
 
Table 4-40 Lethal effects benzo[a]pyrene with mDarT 
 
Effects Time 
Negative 
control 
(B[a]P)  
MAS 
control
(βNF)  
MAS 
B[a]P 
6 µM  
MAS 
B[a]P 
12 µM  
MAS 
B[a]P 
25 µM  
MAS 
B[a]P 
50 µM  
- - 1 - - - 2 1 1 2 - 2 1 1 - - - - 
- - 1 - - - 2 3 3 4 1 2 4 6 2 - 2 1 
Coagulated 
eggsa 
8 hpf 
24 hpf
48 hpf - - 1 - - - 2 3 3 5 1 2 4 6 2 - 2 1 
                    
Note. 
a Three independent experiments values are represented in each group 
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The following terms were abbreviated: B[a]P: Benzo[a]pyrene; MAS: Metabolic Activation System; hpf: 
hours post fertilization; - : No lethality observed. 
 
 Table 4-41 summarizes the lethal effects observed in fish eggs 
incubated with different concentrations of metabolized B[a]P. Lethality 
increased with the time for the first 3 concentrations from 8 hpf to 24 hpf due to 
early severe impairments leading to coagulation. However, a significant 
decrease in coagulated fish embryos (3 out of 60 fish eggs) was observed for 
the highest concentration (50 µM B[a]P). Lethality was not significantly different 
between test and control groups. 
  
Table 4-41 Overview of lethal and teratogenic effects of benzo[a]pyrene with mDarT 
 
Negative
controla 
Test groups 
48 hpf 
B[a]P 
50 µM 
MAS 
control 
(βNF) 
MAS  
B[a]P 
6 µM 
MAS  
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
N Teratogenic eggs - - - - - 1 2 1 4 1 1 2 3 4 4 - 4 2 
N Lethal egg - - 1 - - - 2 3 3 5 1 2 4 6 2 - 2 1 
N Normal eggs 20 20 19 20 20 19 16 16 13 14 18 16 13 10 14 20 14 17
Σ Teratogenic eggs - 1 7 4 11 6 
Σ Lethal eggs 1 - 8 8 12 3 
Σ Normal eggs 59 59 45 48 37 51 
% Teratogenic eggsb - 2 (±3) 14 (±9) 8 (±3) 23 (±5) * 11 (±11)
% Lethal eggsc 2 (±3) - 13 (±3) 13 (±10) 20 (±10) 5 (±5) 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, βNF induced rat liver XenoTech 
microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
a Three independent experiments values are represented in each group 
b Mean percentage ± SD of teratogenic eggs based on surviving eggs (3 experiments) 
c Mean percentage ± SD of lethal eggs based on all eggs (3 experiments) 
*At p < 0.05, there was a significant difference with the other groups 
Every control and test group had a DMSO final concentration of 0.2% (v/v). 
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The following terms were abbreviated: B[a]P: Benzo[a]pyrene; MAS: Metabolic Activation System; βNF: β-
Naphthoflavone; -: No embryo effects; Σ: Sum; N: Number; v/v: volume/volume. 
 
 As summarized in Tab. 4-41, at the lowest concentration (6 µM) 7 
teratogenic eggs were detected (14% of surviving embryos). At 12 µM, 4 fish 
embryos (8% of surviving embryos) displayed abnormalities. There was a 
significant increase (p < 0.05) in teratogenic eggs at 25 µM with 11 fish eggs 
exhibiting multiple malformations (23% of surviving embryos), including growth 
retardation (see Fig. 4-6 A) or head malformations (see Fig. 4-6 C). The number 
of impaired eggs for the highest concentration (50 µM) dropped with 6 fish 
embryos (11% of surviving embryos) showing defects, mainly on the tail (see 
Fig. 4-6 B and D). In spite of teratogenic clear effects in fish embryos exposed 
to different concentrations, there was no concentration-dependent effect. 
 
 The absolute and relative incidences of the different B[a]P-induced 
teratogenic endpoints are summarized in Table 4-42. With the exception of 
rachischisis all possible malformations listed in Table 3-2 were observed in fish 
embryos treated with metabolized B[a]P. According to the criteria mentioned in 
section 4.2.1.2, as 8 fish eggs exposed to B[a]P displayed one or more 
teratogenic effects, a fingerprint-endpoint must be observed in at least 14 fish 
eggs within the 3 experiments. 
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Table 4-42 Overview of teratogenic effects of benzo[a]pyrene metabolite(s) on zebrafish D. rerio embryonic development 
 
Control groups Test groups 
Malformations Time Negative 
Control 
(B[a]P) 
MAS 
Control 
(βNF) 
MAS 
B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
Σt 
Head 
24 hpf 
48 hpf 
- 
- 
2/60 
- 
4/52 
1/52 (2%)a 
2/53 
1/52 (2%) 
4/48 
3/48 (6%) 
1/57 
- 
 
5/28b 
Tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
1/52 (2%) 
- 
- 
- 
1/48 (2%) 
- 
1/57 (2%) 
 
3/28 
End tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
3/52 (6%) 
1/53 
1/52 (2%) 
1/48 
2/48 (4%) 
- 
- 
 
6/28 
Sacculi/Otoliths 
24 hpf 
48 hpf 
- 
- 
- 
- 
3/52 
3/52 (6%) 
2/53 
1/52 (2%) 
4/48 
3/48 (6%) 
- 
1/57 (2%) 
 
8/28 
Heart 48 hpf - 1/60 (2%) 1/52 (2%) 1/52 (2%) 7/48 (15%) 3/57 (5%) 12/28 
Spinal Cord Structure 
24 hpf 
48 hpf 
- 
- 
- 
- 
2/52 
4/52 (8%) 
2/53 
1/52 (2%) 
3/48 
2/48 (4%) 
- 
1/57 (2%) 
 
8/28 
Scoliosis 
24 hpf 
48 hpf 
- 
- 
- 
- 
1/52 
3/52 (6%) 
- 
1/52 (2%) 
1/48 
2/48 (4%) 
- 
2/57 (2%) 
 
8/28 
Rachischisis 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
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Table 4-32 to be continued 
Malformations Time 
Negative 
Control 
(B[a]P) 
MAS 
Control 
(βNF) 
MAS 
B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
Σt 
Deformity of Yolk 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
2/52 (4%) 
1/53 
- 
- 
3/48 (6%) 
- 
1/57 (2%) 
 
6/28 
Growth Retardation 
24 hpf 
48 hpf 
- 
- 
- 
- 
1/52 
- 
- 
- 
- 
1/48 (2%) 
- 
- 
 
1/28 
Sum of teratogenic eggsc -/59 1/60 7/52 4/52 11/48 6/57  
 
Note. 
One teratogenic egg can display multiple malformations 
a Number of eggs displaying this endpoint / number of surviving eggs (%) 
b Sum of the teratogenic eggs per group / number of teratogenic eggs after 48 hpf 
c Sum of the teratogenic eggs per group / number of surviving eggs after 48 hpf 
The following terms were abbreviated: B[a]P: Benzo[a]pyrene; MAS: Metabolic Activation System; hpf: hours post fertilization; βNF: β-Naphthoflavone; -: No embryo 
effects; Σt: Sum of the teratogenic eggs per endpoint out of all teratogenic eggs in the 4 test groups after 48 hpf. 
 
 
 No malformation fulfilled the “fingerprint” criteria. Therefore no characteristic teratogenic endpoint was detected for 
B[a]P in fish embryos. 
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Figure 4-6 Inverted microscope image of fish embryos exposed to benzo[a]pyrene and 
microsomes. 
 A. 24 hpf, 25 µM B[a]P. B. 24 hpf, 50 µM B[a]P. C. 48 hpf, 25 µM B[a]P. D. 48 hpf, 
50 µM B[a]P. The following terms are abbreviated: ET: End Tail; H: Head; Ht: 
Heart; NoT: No Tail is developed; SC: Spinal Cord; S: Scoliosis; S/O: 
Sacculi/Otoliths; T: Tail. 
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 In Figure 4-7, the teratogenic effects are presented depending on the 
B[a]P concentrations and the anatomic region within the fish embryo. Figures 4-
7 A, 4-7 B and 4-7 C display frontal, axial and ventral malformations, 
respectively. Figure 4-7 D summarizes growth retardation. 
 There was no concentration-response for any of the teratogenic effects 
at the frontal (Fig. 4-7 A) axial (Fig. 4-7 B) or ventral (Fig. 4-7 C) zones. There 
was no effect on growth retardation (Fig. 4-7 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7 Summary of individual morphologic malformations in zebrafish D. rerio embryos 
exposed to benzo[a]pyrene and microsomes 48 hpf.  
   Effects on the frontal zone (A), on the axial zone (B) and on the ventral zone (C) are 
   differentiated. (D). Benzo[a]pyrene-induced growth retardation. The standard deviation for 
   each parameter is the result of 3 independent experiments. 
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 Based on these 3 studies, there was no concentration-response of 
B[a]P in the mDarT, with a drop of lethal and teratogenic effect at 50 µM. 
However, the incidence of malformations in fish embryos combined with B[a]P 
and MAS reached significance (p < 0.05) at 25 µM. In spite of the teratogenic 
effects observed, no clear fingerprint was identified with B[a]P metabolites on 
zebrafish D. rerio embryos. 
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4.2.4 Thalidomide 
4.2.4.1  Concentration range finding 
 
 A concentration range finding study with multiple concentrations of 
thalidomide (Thal) alone was investigated with 20 fish embryos per group (see 
Tab. 4-43). 
 
Table 4-43 Influence of thalidomide on zebrafish D. rerio development 
 
Internal 
control 
Thalidomide groups 
48 hpf Tris-HCl 
0.1 M 
0.2% DMSO
(v/v) 
Thal 
100 µM 
Thal 
200 µM 
Thal 
400 µM 
N Teratogenic eggs - - - - 
N Lethal eggs - 2 - 1 
N Normal eggs 20 18 20 19 
% Normal eggs  100 90 100 95 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, and PP test tubes. 
Note: 
The following terms were abbreviated: Thal: Thalidomide; DMSO: Dimethyl Sulfoxide; -: No embryo 
effects; N: Number; v/v: volume/volume. 
 
 The internal control and thalidomide groups fulfilled the validation 
criterion (≤ 10% impaired embryos). Therefore, Thal concentration up to 400 µM 
was combined with MAS. 
 
4.2.4.2 Overview 
 
 Although much careful work has been done in an attempt to 
understand the mechanism of action of thalidomide, the reason for the chemical 
and species specificity remain unclear. In in vivo studies, rats are least sensitive 
to thalidomide whereas rabbits display concordant limb malformations to 
Results 
120 
humans (see Chapter 1.5.4.3.). Therefore, rabbit liver microsomes were used to 
be combined with the fish embryos. 
4.2.4.3 Controls 
 
 As shown in Tables 4-44 and 4-45, no coagulated or teratogenic egg 
were observed in the 3 negative control experiments each consisting of 20 fish 
embryos exposed to 400 µM Thal without MAS. In the 3 MAS control 
experiments, 1 teratogenic effect (heart malformation) was observed and 2 out 
of 60 fish eggs were coagulated (3% of all fish eggs). However, for each control 
group and for the 3 experiments, the acceptance criterion of ≤ 10% impaired 
embryos 48 hpf was satisfied and, thus, the experiments were considered to be 
valid. 
 
4.2.4.4 Lethal and/or teratogenic effects of metabolic activated 
thalidomide in D. rerio embryos 
 
 Lethal and/or teratogenic effects observed 48 hpf in fish embryos 
incubated with both thalidomide and rabbit liver microsomes, are summarized in 
Tables 4-44, 4-45 and 4-46. 
  
Table 4-44 Lethal effects of thalidomide with mDarT 
 
Effects Time 
Negative 
controla 
(Thal) 
MAS 
control 
(Rabbit) 
MAS 
Thal 
100 µM 
MAS 
Thal 
200 µM 
MAS 
Thal 
400 µM 
- - - - - - - - - - - - - - - 
- - - - 1 1 - - - - - - - - 1 
Coagulated 
Eggs 
8 hpf 
24 hpf 
48 hpf - - - - 1 1 - - - - - - 2 - 1 
                 
Note. 
a Three independent experiments values are represented in each group 
The following terms were abbreviated: Thal: Thalidomide; MAS: Metabolic Activation System; hpf: hours 
post fertilization; - : No lethality observed. 
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 Table 4-44 summarizes the lethal effects observed in fish eggs 
incubated with different concentrations of metabolized thalidomide. Lethality 
was only observed in the highest concentration (400 µM). However, lethality 
was not significantly different between test and control groups.  
 
Table 4-45 Overview of lethal and teratogenic effects of thalidomide with mDarT 
 
Negative 
controla 
Test groups 
48 hpf 
Thal 
400µM 
MAS 
control 
(Rabbit) 
MAS 
Thal 
100 µM 
MAS 
Thal 
200 µM 
MAS 
Thal 
400 µM 
N Teratogenic eggs - - - - - 1 - 1 - - 1 - 3 4 2 
N Lethal eggs - - - - 1 1 - - - - - - 2 - 1 
N Normal eggs 20 20 20 20 19 18 20 19 20 20 19 20 15 16 17 
Σ Teratogenic eggs - 1 1 1 9 
Σ Lethal eggs - 2 - - 3 
Σ Normal eggs 60 57 59 59 48 
% Teratogenic eggsb -  2 (±3) 2 (±3) 2 (±3) 16 (±5)* 
% Lethal eggsc - 3 (±3) - - 5 (±5) 
 
Incubation conditions: 60 min, 32°C, Tris-HCl (0.1 M), 2 hpf at pH 7.6, non-induced rabbit liver 
XenoTech microsomes (0.7 mg/ml), NADPH (1 mM) and PP test tubes. 
Note.  
a Three independent experiments values are represented in each group 
b Mean percentage ± SD of teratogenic eggs based on surviving eggs (3 experiments) 
c Mean percentage ± SD of lethal eggs based on all eggs (3 experiments) 
*At p < 0.05, there was a significant difference with the other groups 
Every control and test group had a DMSO final concentration of 0.2% (v/v) 
The following terms were abbreviated: DMSO: Dimethyl Sulfoxide; Thal: Thalidomide; MAS: Metabolic 
Activation System; -: No embryo effects; Σ: Sum; N: Number, v/v: volume/ volume. 
 
 In the test groups, the incidence of eggs displaying malformations 
(teratogenic eggs/surviving eggs) increased with increasing Thal concentrations 
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from 2% (100 and 200 µM thalidomide- see Fig. 4-8 A) to 16% (400 µM) 
reaching significance at the highest Thal concentration (p < 0.05) (Table 4-45).  
 The absolute and relative incidences of the different thalidomide-
induced teratogenic endpoints in zebrafish are summarized in Table 4-46. With 
the exception of scoliosis and rachischisis all possible malformations listed in 
Table 3-2 were observed in fish embryos treated with metabolized Thal. 
However, some malformations, such as effects on the head, occurred more 
frequently than others. According to the criteria mentioned in section 4.2.1.2, as 
11 fish eggs exposed to Thal displayed 1 or more teratogenic effects, a 
fingerprint-endpoint must be observed in at least 6 fish eggs within the 3 
experiments (Tab. 4-46). 
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Table 4-46 Overview of teratogenic effects of thalidomide metabolite(s) on zebrafish D. rerio embryonic development 
Control groups Test groups 
Malformations Time Negative 
control 
(Thal)  
MAS control 
(Rabbit) 
MAS 
Thal 
100 µM 
MAS 
Thal 
200 µM 
MAS 
Thal 
400 µM 
Σt 
Head 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
1/60  
1/60 (2%)a 
1/59 
2/57 (4%) 
 
6/11b (55%)c 
Tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
1/59 
- 
 
- 
End tail 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
1/60 (2%) 
- 
1/57 (2%) 
 
2/11 
Sacculi/Otoliths 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
1/60 
1/60 (2%) 
1/59 
5/57 (9%) 
 
6/11 (55%) 
Heart 48 hpf - 1/59 (2%) - 1/60 (2%) 5/57 (9%) 6/11 (55%) 
Spinal Cord Structure 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1/57 (2%) 
 
1/11 
Scoliosis 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
Rachischisis 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
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Table 4-46 to be continued 
Malformations Time 
Negative 
control 
(Thal) 
MAS control 
(Rabbit) 
MAS 
Thal 
100 µM 
MAS 
Thal 
200 µM 
MAS 
Thal 
400 µM 
Σt 
Deformity of Yolk 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
1/60 (2%) 
1/60 
1/60 (2%) 
- 
2/57 (4%) 
 
4/11 
Growth Retardation 
24 hpf 
48 hpf 
- 
- 
- 
- 
- 
- 
- 
- 
1/59 
- 
 
- 
Sum of teratogenic eggsc -/60 1/59 1/60 1/60 9/57  
 
Note. 
One teratogenic egg can display multiple malformations 
a Number of eggs displaying this endpoint / number of surviving eggs (%) 
b Number of eggs displaying this endpoint / total number of teratogenic eggs in the test groups. 
c Major malformations (> 50%) represented in bold 
d Sum of the teratogenic eggs per group / number of surviving eggs after 48 hpf 
The following terms were abbreviated: Thal: Thalidomide; MAS: Metabolic Activation System; hpf: hours post fertilization; -: No embryo effects; Σt: Sum of the 
teratogenic eggs per endpoint out of all teratogenic eggs in the 3 test groups after 48 hpf. 
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According to the above-mentioned definition of fingerprint malformations, the 
major endpoints are shown in Figure 4-8. Effects on the head (6/11), 
sacculi/otoliths (6/11) (Fig. 4-8 B, C and D), (Fig. 4-8 C), and the heart (19/37) 
(Fig. 4-8 B, C and D) were predominant thalidomide-induced malformations in 
D. rerio embryos (≥ 50% of all teratogenic fish eggs in the test groups).  
 
    
 
     
 
Figure 4-8 Inverted microscope image of fish embryos exposed to thalidomide and 
microsomes 
A. 24 hpf, 200 µM Thal. B. 48 hpf, 200 µM Thal. C. 24 hpf, 400 µM Thal. D. 48 
hpf, 400 µM Thal. The following terms are abbreviated: H: Head; Ht: Heart; S/O: 
Sacculi/Otoliths; T: Tail; YS: Yolk sac. 
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 In Figure 4-9, the teratogenic effects are presented depending on the 
thalidomide concentrations and the anatomic region within the fish embryo. 
Figures 4-9 A, 4-9 B and 4-9 C display frontal, axial and ventral malformations, 
respectively. A concentration-response was observed for the major endpoints 
on the frontal (Fig. 4-9 A) and ventral (Fig. 4-9 C) zones. The malformations 
(when present) on the axial region were independent of thalidomide 
concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-9 Summary of individual morphologic malformations in zebrafish D. rerio embryos 
exposed to thalidomide and microsomes 48 hpf.  
   Effects on the frontal zone (A), on the axial zone (B) and on the ventral zone (C) are 
   differentiated. The standard deviation for each parameter is the result of 3 independent 
   experiments. Abbreviations: Thal: Thalidomide; MAS: Metabolic Activation System. 
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 Based on these 3 studies, an increase in teratogenic incidences was 
observed with increasing concentrations of metabolic activated thalidomide, 
reaching significance (p < 0.05) at 400 µM. However, lethality was not 
significantly different between the control and test groups. Nevertheless, 3 
characteristic malformations (effects on the head, sacculi/otoliths, and heart) 
were identified in fish embryos exposed to metabolically activated thalidomide. 
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5 Discussion 
 
 We have demonstrated the successful combination of the fish embryo 
assay, used for screening for embryotoxic/teratogenic effects, with a 
mammalian metabolic activation system (i.e., rat liver microsomes). The 
efficiency of this advanced in vitro screening model was tested using 4 
mammalian proteratogens, namely, cyclophosphamide, ethanol, 
benzo[a]pyrene and thalidomide, as references. It was shown that the exposure 
of fish eggs to each proteratogen alone didn’t result in any significant 
teratogenic effect. Only the presence of the mammalian metabolic activation 
system triggered the formation of teratogenic and lethal effects in the exposed 
fish embryos. 
 
 With the exemption of rachischisis all teratogenic endpoints listed in 
Table 3-2 were observed in fish embryos exposed to metabolically activated 
CPA. The incidences of lethality and most teratogenic effects were clearly 
concentration-dependent and significantly increased (p < 0.01) in test groups 
exposed to 14 and 28 mM CPA. Moreover, a significant increase (p < 0.01) in 
lethality was observed in the highest concentration group (28 mM CPA). The 
major malformations, i.e., the teratogenic endpoints with the highest incidences, 
comprised effects on the head, the sacculi/otoliths and the spinal cord structure. 
These effects were defined as fingerprint-endpoints in fish embryos according 
to the definition provided in section 4.2.1.2. Like many other antineoplastic 
agents, CPA has been reported to elicit a full spectrum of developmental 
toxicities in mammals, including mice (Hackenberg and Von Kreybig, 1965), rats 
(Murphy, 1962) and rabbits (Gerlinger and Clavert, 1964). Defects included 
growth retardation (reduced fetal body weight) and effects on the limb, digit, 
palate and jaw when administered intraperitoneally during organogenesis at 
dose levels of 2 to 50 mg/kg/day. In humans, a specific syndrome of defects 
was identified, including congenital malformations of the digit, palate, ears, face, 
skin and in some cases the skull (Schardein and Macina, 2007). Thus, some of 
the major effects observed in fish embryos exposed to metabolically activated 
CPA are similar to characteristic anomalies observed in animals and humans.  
  
As with CPA, exposure to ethanol without an external metabolic 
activation system was insufficient to induce any significant developmental 
malformations in fish embryos up to a concentration of 170 mM. Only the 
concomitant use of ethanol and microsomes provoked lethality and 
teratogenicity starting at the lowest concentration (42.5 mM). As demonstrated 
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by other groups, ethanol is able to induce malformations in fish embryos without 
a metabolic activation system and, thus, acting as a direct teratogen in this test 
system (Reimers et al., 2004; Reimers et al., 2006). However, these teratogenic 
effects were observed only at higher ethanol concentrations (200 mM) and/or 
increased incubation times. In fish eggs exposed to ethanol and microsomes, a 
clear increase in teratogenic incidences was observed with increasing 
concentrations of metabolic activated ethanol, reaching significance (p < 0.05) 
at 85 and 170 mM ethanol, respectively. In addition, lethality was significantly 
increased (p < 0.05) at the highest test material concentration (170 mM 
ethanol). Again, all malformations with the exception of rachischisis, were 
observed in fish embryos with different incidences. Based on the definition of 
fingerprint-endpoints, effects on the spinal cord structure, the sacculi/otoliths, 
the head as well as scoliosis were the major malformations observed. It is well 
known that ethanol is teratogenic in animals and humans. In vivo studies in 
several species (e.g., mice, rats, rabbits, guinea pigs) clearly demonstrated 
potent developmental toxicity, including retarded fetal growth, increased 
mortality and malformations. In humans, the most typical abnormalities are 
associated with the central nervous system, the craniofacial development, the 
cardiac system and the skeleton (Schardein and Macina, 2007). Again, major 
ethanol-induced effects observed in the fish embryos are similar to effects 
observed in ethanol exposed mammals and especially in humans. The 
malformations of the head and the spinal cord observed in fish embryos 
correspond to the craniofacial and skeletal abnormalities in humans. 
 
As for the previous compounds, benzo[a]pyrene alone did not provoke 
significant lethal or teratogenic effect. The incidence of malformations on fish 
embryos combined with benzo[a]pyrene and MAS reached significance (p < 
0.05) at 25 µM. However, there was no difference between the controls and the 
test groups in lethality. Moreover, there was no concentration-response due to a 
drop of lethal and teratogenic effects at the highest concentration (50 µM 
benzo[a]pyrene). Insolubility may explain those results. Indeed, if a 
heterogenous suspension is formed within the test tube, the compound quickly 
precipitates of solution as large particles and may not be able to interact with 
metabolizing enzymes in the liver microsomes, leading to no or little 
biotransformation. Furthermore, its high lipophilicity (logK(OW) = 6) may 
contribute to non-specific binding with microsomes, chorion and plasticware 
which may limit the benzo[a]pyrene free part in the suspension and at last 
reduce its biotransformation (Di et al., 2006). Again, high lipophilicity of 
benzo[a]pyrene could inhibit enzyme activity by denaturing microsomes vesicles 
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3D structure (N. Hewitt, personal communication). Specific malformations on 
the fish eggs based on the definition of fingerprint-endpoints were not detected 
even though there were pronounced teratogenic effects. In mammals, 
benzo[a]pyrene is known to be teratogenic with mice being the most sensitive 
species. Reported defects include, exencephaly, thoraco- and gastroschisis, 
phocomelia and oedema (Shepard and Lemire, 2004). Benzo[a]pyrene-induced 
effects detected in the fish embryos were not specific and could not be 
compared with mammals. 
 
Exposure to thalidomide without an external metabolic activation system 
did not significantly induce malformations in fish embryos up to a concentration 
of 400 µM. Only the concomitant use of thalidomide and rabbit liver microsomes 
provoked little but significant teratogenicity (p < 0.05) at the highest 
concentration tested. However, lethality was not affected at any concentration. 
Based on the definition of fingerprint-endpoints, effects on the sacculi/otoliths, 
the head as well as heart were the major malformations observed in the fish 
embryos. In mammals, thalidomide teratogenicity is species specific. In vivo 
studies in the most sensitive species (e.g., rabbits and monkeys) clearly 
demonstrated potent developmental toxicity, including retarded foetal growth 
and limb malformations. In humans, the most typical abnormalities are 
associated with the limbs (e.g., phocomelia), the central nervous system, the 
face, the ears, the cardiac system and the abdominal and visceral organs (Brent 
and Holmes, 1988). Major thalidomide-induced effects observed in the fish 
embryos are similar to effects observed in thalidomide exposed in humans but 
not in animals. Malformations of the head, the sacculi/otoliths and the heart 
observed in fish embryos correspond to the face, the ears and the cardiac 
system in humans. However, no concordant limb reduction defects were 
detected in fish embryos which are considered to be the most likely to occur 
when associated with thalidomide exposure in humans (Brent and Holmes, 
1988). Furthermore, there is yet no agreement that (i) limb reduction defects 
would actually be present or detectable in fish embryos and (ii) what can be 
considered as a limb reduction defects in fish embryos. Furthermore, 
thalidomide effectiveness in humans produces severe limb reduction defects 
during a very narrow period of early organogenesis from the 22nd to the 36th day 
post conception whereas fish embryos exposure time with MAS covers the 
blastula period. Thus, fish embryos could be further incubated during 
organogenesis (75% Epiboly stadium) with MAS and thalidomide to investigate 
any teratogenic effects. Besides the exposure time, the activation system (i.e., 
rabbit liver microsomes) might not be suitable to provoke limb reduction defects.  
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Based on these results, hydrophilic compounds (cyclophosphamide and 
ethanol) appeared to be intensively metabolized with the MAS inducing severe 
abnormalities on fish embryos while the more lipophilic test materials 
(benzo[a]pyrene and thalidomide) didn’t provoked pronounced lethal and 
teratogenic effects: (i) Non-specific binding to microsomes, chorion and 
plasticware may reduce the free part of the test material in the test tubes and (ii) 
non-homogenous solution as well as (iii) hydrophobic effects are likely to limit 
lipophilic compounds biotransformation. Further input should be done on the 
standard test conditions for sample preparation. 
 
Numerous advantages make this model an excellent in vitro alternative 
method to screen for teratogenic effects; (i) short time of the assay based on 
the short embryonic development (48 hpf, from the oviposition to the end of the 
test) (ii) the huge number of fish eggs daily available to perform screening 
studies and (iii) the ease to applying this technique in new facilities.  
 
However, despite these advantages some limitations of the system have 
to be taken into account: (i) The chorion membrane enclosing the fish embryo 
might limit the uptake of very lipophilic substances or substances with a high 
molecular weight making it difficult to detect their proteratogenic potential (ii) 
Due to the toxicity of the microsomes to the fish embryos the contact time with 
the test material is limited to 1 hour, i.e., the fish embryos are exposed to the 
test item only during a small part of the developmental period. Although the 
exposure time covers the most sensitive phase of fish developmental period (as 
demonstrated with CPA, ethanol), some proteratogens, which are active at a 
later developmental stage, might be missed. (iii) The CYP P450 activity of liver 
microsomes depends on the inducing compound, with which the rats were 
treated. In general, the use of microsomes exhibiting a broad range of CYP 
activities is preferred (e.g., by using Phenobarbital/β-naphthoflavone-induced 
microsomes). However, proteratogens activated by a specific CYP P450 
isoenzyme (e.g., CYP 2E1) might exhibit lower activity or might be even missed 
when using generally induced microsomes. Therefore, the application of 
different liver microsomes from rats treated with different inducers should be 
considered depending on the test material. 
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6 Conclusion 
 
 For the first time it has been described that an exogenous mammalian 
activation system (i.e., rat and rabbit liver microsomes) was successfully 
incorporated with zebrafish D. rerio embryos for the detection of teratogenic 
effects. Based on the results of cyclophosphamide, ethanol, benzo[a]pyrene 
and thalidomide, it could be shown that only the combination of the fish 
embryos with the metabolic activation system was able to detect the 
developmental toxicity of these proteratogenic compounds. For 
cyclophosphamide, ethanol and thalidomide a concentration-response 
relationship was shown and the qualitative nature of the malformations was 
similar between fish embryos and humans. Benzo[a]pyrene was demonstrated 
to be significantly teratogenic in fish embryos in spite of a lack of concentration-
response and specific teratogenic fingerprints. 
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7 Outlook 
 
In the future, a series of experiments should be performed to prove that 
the proteratogen metabolites of CPA, ethanol, B[a]P are active (if commercially 
available) within the fish eggs and compare them with the results obtained with 
the parent compound and MAS. Moreover, other known proteratogens if 
possible referring to a class of chemical or being a specific CYP family 
substrate should be tested in order to establish a database. Furthermore, 
microsome activity should be further demonstrated using (i) CYP inhibitors, or 
(ii) test material detoxified by the MAS (e.g., Cytochalasin D). Other efforts 
should be made (i) in testing others liver subcellular fractions (e.g., S9-mix, 
human microsomes) (ii) in the evaluation of this fish egg teratogenic tool, as the 
emergence of genomic and proteomic methods for zebrafish are now available. 
Lastly, a clear strategy must be established for the screening of new 
compounds. Metabolic stability assessed during xenobiotic development 
process or quantitative structure-activity relationship (QSAR) may give a clue to 
the CYP family involved in its metabolism. This can first orientate the choice of 
the appropriate animal induced liver microsomes. However, if no information are 
available, the test material might be incubated with induced liver microsomes 
covering a broad range of CYP activities. If the results were not satisfactory, it 
should be further refined using induced liver microsomes representing specific 
major human isoforms involved in the biotransformation of xenobiotics, namely 
CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4. Furthermore, a 
positive control (e.g., CPA, ethanol) should always be incorporated in the test 
system to assess MAS activity when screening new compounds.  
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8 Summary 
 
The assessment of teratogenic effects of chemicals is generally performed 
using in vivo teratogenicity assays e.g., in rats or rabbits. Following the 3R 
principles, the development of alternative methods is encouraged to reduce the 
number of animal tests. From this perspective, we have developed an in vitro 
assay (mDarT) using the zebrafish Danio rerio embryo teratogenicity assay 
(DarT) combined with an exogenous mammalian metabolic activation system 
(MAS), able to biotransform proteratogenic compounds. Cyclophosphamide, 
ethanol, benzo[a]pyrene and thalidomide were used as test materials to assess 
the efficiency of this assay. Briefly, the zebrafish embryos were co-cultured at 2 
hpf (hours post fertilization) with the test material at varying concentrations, 
mammalian liver microsomes from different species and NADPH for 60 min at 
32°C under moderate agitation in Tris buffer. The negative control (test material 
alone) and the MAS control (MAS alone) were incubated in parallel. For each 
test group, 20 eggs were used for statistical robustness. Afterwards fish 
embryos were transferred individually into 24-well plates filled with fish medium 
for 48 hours at 26°C with a 12 hour-light cycle. Teratogenicity was scored after 
24 and 48 hpf using morphological endpoints. The test was considered to be 
valid if a minimum of 90% of fish eggs developed normally for the two controls 
(test material alone and MAS alone). For each test material, the experiment was 
repeated three times with the controls satisfying the validation criteria (≤ 10% 
impaired embryos). Indeed, no significant teratogenic effects were observed 
compared to controls in fish embryos exposed to the proteratogens alone (i.e., 
without metabolic activation) or the MAS alone. In contrast, the four test 
materials induced significant abnormalities in fish embryos when co-incubated 
with animal liver microsomes. For cyclophosphamide, ethanol and thalidomide a 
concentration-response relationship was shown and the qualitative nature of the 
malformations was similar between fish embryos and humans. Benzo[a]pyrene 
was demonstrated to be significantly teratogenic in fish embryos in spite of no 
concentration-response and unspecific teratogenic fingerprints. We conclude 
that the application of animal liver microsomes will improve and refine the DarT 
as a predictive and valuable alternative method to screen teratogenic 
substances. 
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ACN: Acetonitrile 
ADME: Absorption, Distribution, Metabolism and Excretion 
ANOVA: Analysis of Variance 
AT: Acetyl Transferase 
Aro: Aroclor1254 
B[a]P: Benzo[a]pyrene 
BCA: Bicinchoninic Acid 
BMELV: Bundesministerium für Ernährung, Landswirstchaft und 
Verbraucherschutz 
βNF: β-Naphthoflavone 
BSA: Bovin Serum Albumin 
CPA: Cyclophosphamide 
CYP P450 or CYP: Cytochrome P450 
DarT: Zebrafish D. rerio Teratogenic assay 
DEX: Dexamethasone 
DIN: Deutsch Industrie Norm 
DMEM: Dulbecco’s modified eagle medium 
DMSO: Dimethyl sulfoxide 
DOC: Dynamic organ culturing 
E: Eye  
ECVAM: European Center for the Validation of Alternative Methods 
EDTA: Ethylenediaminetetraacetic acid 
EHs: Epoxide Hydrolases 
ENL: Erythema Nodosum Leprosum 
ET: End tail 
EtOH: Ethanol 
ER: Endoplasmic Reticulum 
EST: Embryonic stem cell test 
FAS: Fetal Alcohol Syndrome 
FET: Fish embryo toxicity test 
FETAX: Frog Embryo Teratogenic Assay: Xenopus 
FM: Fish Medium 
FMOs: Flavin Monooxygenases 
GST: Glutathione S-transferase 
GT: Glutathione 
H: Head 
Ht: Heart 
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hpf: hours post fertilization 
ICCVAM: Interagency coordinating commitee on the validation of 
alternatives methods 
INH: Isoniazid or Isonicotinyl Hydrazine 
IVT: In Vitro Technologies 
MAS: metabolic activation system 
mDarT: metabolic Zebrafish D. rerio Teratogenic assay 
mEHs: microsomal Epoxide Hydrolases 
MM: Micromass test  
NADPH: nicotinamide adenine dinucleotide phosphate reduced 
n.d.: no data 
NoT: No Tail detached 
NRS: NADPH Regenerating System 
OECD: Organization for Economic Cooperation and Development 
PAHs: Polycyclic Aromatic Hydrocarbons 
PAPS: 3’-Phosphoadenosine 5’-Phosphosulfate 
PIC: Protein Inhibitor Cocktail 
PB: Phenobarbital 
PO: Pericardial Oedema 
PP: Polypropylene 
QMS: Quality Management System 
REACH: Registration, Evaluation, and Authorization of Chemicals 
ROS: Reactive Oxygen Species 
rpm: rotation per minute 
RT: Room temperature 
S: Scoliosis 
SC: Spinal Cord 
SD: Standard deviation 
sEH: Soluble epoxide hydrolase 
S/O: Sacculi/otoliths 
SM: Somites 
STs: Sulfotransferases 
T: Tail 
Thal: Thalidomide 
UDPGA: α-D-UDP-glucuronic acid 
UGT: UDP-glucuronosyltransferase 
v/v: volume/volume 
WEC: Whole embryo culture 
YS: Yolk sac 
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YSE: Yolk sac extension  
YSO: yolk sac oedema 
ZEBET: Die Zentralstelle zur Erfassung und Bewertung von Ersatz- und 
Ergänzungsmethoden zum Tierversuch 
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heart structure in the zebrafish D. rerio. At 48hpf, in fish embryos, the normal 
looping process places the ventricle and atrium side by side, so that the two 
chambers largely overlap each other in lateral view (Antkiewicz et al., 2005). 
 
sacculi/otoliths. This is the primitive ear structure in the zebrafish D. rerio 
embryo. The zebrafish possess two otoliths per sacculi. The otoliths are dark 
round bones within the sacculi (or vesicle). The otoliths malformations included 
one to multiple otoliths per sacculi. The sacculi malformations included 
abnormally shaped vesicles (Reimers et al., 2004). 
 
somites. Undifferenciated mesodermal component of an early trunk or tail 
segment or metamere, derived from paraxial mesoderm; forms the myotome, 
the sclerotome and perhaps the dermatome (Kimmel et al., 1995). 
 
yolk. Nutrient store for embryonic development in the form of semicrystalline 
phospholipoprotein and contained within yolk granules (Kimmel et al., 1995) 
 
yolk sac. Giant syncitial uncleaved cells containing the yolk; underlies the 
blastodisc early, and becomes enveloped by the blastoderm during epiboly 
(Kimmel et al., 1995) 
 
yolk sac extension. The posterior elongated region of the yolk sac that forms 
during the segmentation period (Kimmel et al., 1995) 
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14 Annex A 
 
a) Cyclophosphamide 
 
 The protocol for CPA drug biotransformation with mDarT is displayed 
in Table 14-1. CPA stock solution was dissolved in Tris-buffer and stored on ice. 
 
Table 14-1 Protocol for CPA with mDarT 
 
 
MAS 
 
CPA 
28 mM 
MAS 
CPA 
3.5 mM
MAS 
CPA 
7 mM 
MAS 
CPA 
14 mM 
MAS 
CPA 
28 mM 
Tris-HCl (0.1 M) 910 380 810 710 510 110
Microsomes (20 mg/ml) 70 - 70 70 70 70
CPA (20 mg/ml)  - 800 100 200 400 800
Fish eggs 820 820 820 820 820 820
NADPH (10 mM) 200 - 200 200 200 200
Final Volume 2000 µl 
 
Abbreviations: CPA: Cyclophosphamide; MAS: Metabolic Activation System; -: none. 
Annexes 
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b) Ethanol 
 
 The protocol for ethanol drug biotransformation with mDarT is shown 
in Table 14-2. Ethanol stock solution was stored at room temperature (RT). 
 
Table 14-2 Protocol with ethanol and mDarT 
 
 
MAS 
 
EtOH 
170 mM 
MAS 
EtOH 
42.5 mM 
MAS 
EtOH 
85 mM 
MAS 
EtOH 
170 mM 
Tris-HCl (0.1 M) 910 1160 905 900 890
Microsomes (20 mg/ml) 70 - 70 70 70
EtOH - 20 5 10 20
Fish eggs 820 820 820 820 820
NADPH (10 mM) 200 - 200 200 200
Final Volume 2000 µl 
 
Abbreviations: EtOH: Ethanol; MAS: Metabolic Activation System; -: none 
Annexes 
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 c) Benzo[a]pyrene 
 
 The protocol for B[a]P drug biotransformation with mDarT is 
summarized in Table 14-3. Four B[a]P stock solutions, respectively 3, 6, 12 and 
25 mM, were dissolved in DMSO under dim light in brown glasses and stored at 
RT. 
 
Table 14-3 Protocol with B[a]P and mDarT 
 
 
MAS 
 
B[a]P 
50 µM 
MAS 
B[a]P 
6 µM 
MAS 
B[a]P 
12 µM 
MAS 
B[a]P 
25 µM 
MAS 
B[a]P 
50 µM 
Tris-HCl (0.1 M) 906 1176 906 906 906 906
Microsomes (20 mg/ml) 70 - 70 70 70 70
Fish eggs 820 820 820 820 820 820
DMSO  4 - - - - -
B[a]P - 4 4 4 4 4
NADPH (10 mM) 200 - 200 200 200 200
Final Volume 2000 µl 
Abbreviations: B[a]P: Benzo[a]pyrene; DMSO: Dimethyl Sulfoxide; MAS: Metabolic Activation System; -: 
none. 
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c-1) Aqueous dilution method  
 
 In the aqueous dilution method, as described in Fig. 14-1, an aqueous 
dilution step (Premix) was performed before addition of test material to the MAS 
(step D). 
 
 
 
Figure 14-1 Aqueous dilution method protocol 
 
A: PP test tubes at RT with microsomes diluted in Tris-HCl buffer (0.1 M). B: B[a]P was weighted under 
dim light in brown glasses at RT and dissolved in DMSO. C: PP vial at RT. D: PP test tubes were 
incubated at 32°C; the reaction was started by adding NADPH. Fish eggs and NADPH were previously 
diluted in Tris-HCl buffer (0.1 M).  The following terms were abbreviated: B[a]P: Benzo[a]pyrene; DMSO: 
Dimethyl Sulfoxide; M: Microsomes; PP: polypropylene; RT: room temperature; (v/v): volume/volume; VT: 
Total volume. 
  
Microsomes 
(20 mg/ml) 
Fish eggs 
NADPH 
M + B[a]P 4 µl 
836 µl 
800 µl
200 µl
800 µl
1000 µl 
B[a]P Stock Solution 
DMSO 
VT= 4500 µl 
396 µl 
Premix 
 DMSO 0.5% (v/v) 
Incubation  
DMSO 0.2% (v/v) 
VT= 840 µl VT= 1000 µl VT= 2000 µl 
A
B C
D 
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c-2) Cosolvent method 
 
 As described in Fig. 14-2, the test material is being added directly to 
the microsomal proteins from an organic media (i.e., DMSO and Acetonitrille). 
 
 
Figure 14-2 Cosolvent method protocol 
 
A: B[a]P was weighted under dim light in brown glasses at RT and dissolved in DMSO. B: PP test tubes at 
RT with microsomes diluted in Tris-HCl buffer (0.1 M). C: Brown glasses were filled with 160 µl ACN at RT. 
B[a]P was transferred under dim light. D: PP vial at RT.  E: PP test tubes were incubated at 32°C; the 
reaction was started by adding NADPH. Fish eggs and NADPH were previously diluted in Tris-HCl buffer 
(0.1 M).  The following terms were abbreviated: ACN: Acetonitrille; B[a]P: Benzo[a]pyrene; DMSO: 
Dimethyl Sulfoxide; M: Microsomes; PP: polypropylene; RT: room temperature; (v/v): volume/volume; VT: 
Total volume. 
Microsomes 
(20 mg/ml) 
Fish eggs 
NADPH 
M + B[a]P 21 µl 
819 µl 
800 µl
200 µl
800 µl
1000 µl 
VT= 4400 µl 
395 µl 
Premix            
ACN 2% (v/v) 
DMSO 0.5% (v/v) 
Incubation                      
ACN 0.8% (v/v) DMSO 0.2% (v/v) 
VT= 840 µl VT= 200 µl VT= 2000 µl 
A B
C D
40 µl 
VT= 1000 µl 
E 
B[a]P Stock Solution    
ACN 80% (v/v)            
DMSO 20% (v/v) 
B[a]P Stock Solution     
DMSO  
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d) Thalidomide 
 
In Table 14-4, the protocol for Thal drug biotransformation with the 
mDarT is displayed. Three stock solutions of Thal respectively 5, 10 and 20 mM 
were dissolved in DMSO in brown glasses and stored at RT. 
 
Table 14-4 Protocol of Thal with mDarT 
 
 
MAS 
 
Thal 
400 µM
MAS 
Thal 
100 µM
MAS 
Thal 
200 µM 
MAS 
Thal 
400 µM
Tris-HCl (0.1 M) 906 1176 906 906 906
Microsomes (20 mg/ml) 70 - 70 70 70
Fish eggs 820 820 820 820 820
DMSO  4 - - - -
Thal - 4 4 4 4
NADPH (10 mM) 200 - 200 200 200
Final Volume 2000 µl 
 
Abbreviations: B[a]P: Benzo[a]pyrene; DMSO: Dimethyl Sulfoxide; MAS: Metabolic Activation System; -: 
none. 
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